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Thanatopsis 
 
How doth the little busy cell 
Tread the line ´twixt heav`n and hell? 
Spinning threads of gene commands, 
Repairing errors in the strands, 
Cleaving daughters by mitosis 
Without invoking apoptosis? 
For life is but a tight-rope span, 
A tenuous state for cell, or man: 
With many a killer O2 radical 
From oxidations mitochondrial1. 
 
At least we now have consolation- 
Death`s biocomic explanation – 
Our time to shuffle from this scene`s 
Dictated by gerontogenes2. 
And as we age `tis rather nice 
To learn that dying`s put on ICE3; 
The senile scramblings of our brains 
Are simply due to apopains`s 
Aberrant acts, or morbid mutant4: 
Morituri te salutant! 
 
 
1. Kroemer, G. et al. (1995) FASEB J. 9, 1277-1287 
2. Rattan, S. I. S. (1995) FASEB J. 9, 284-286 
3. Kumar, S. (1995) Trends Biochem. Sci. 20, 198-202 
4. Nicholson, D. W. et. al. (1995) Nature 376, 37-43 
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i. Abbreviations 
AoROI      Area of Region of Interest 
BrdU       5-bromo-2′-deoxyuridine 
BLE       bamboo leaf extract 
CLR       C-type lectin receptor 
COD       chemical oxygen demand 
COX-2      cyclooxygenase-2 
CYP       cytochrome P450 
CXCL8      (C-X-C motif) ligand 8 
DAMP      damage-associated molecular pattern 
DMEM      Dulbecco’s Modified Eagle Medium 
DMSO      dimethyl sulfoxide 
dNTP       deoxynucleoside triphosphate 
ELISA       enzyme-linked immunosorbent assay 
EA       ellagic acid 
ECM       extra cellular matrix 
EGF       epidermal growth factor 
ERK       extracellular signal-regulated kinases 
FCS       fetal calf serum 
GAPDH glyceraldehyde 3-phosphate 
dehydrogenase 
GPCR       G-protein-coupled receptor 
GSH       glutathione 
HaCaT human adult, low calcium, high 
temperature, skin keratinocytes 
HIF       hypoxia inducible factor 
H2O2       hydrogen peroxide 
HUVEC      human umbilical vein endothelial cells 
IF-γ       interferon γ 
IGF-1       insulin-like growth factor-1 
IL-1R       interleukin-1 receptor   
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IL-1Ra      IL-1 receptor antagonist 
IL-1RII      IL-1 receptor type 2 
iNOS       nitric oxide synthase 
JNK       Jun N-terminal kinase 
KGF       keratinocyte growth factor 
LDH       lactate dehydrogenase 
MAPK      mitogen-activated protein kinase 
MCP-1      monocyte chemoattractant protein 1 
M-MLV RT  Moloney Murine Leukemia Virus Reverse 
Transcriptase 
MMP       matrix metalloprotease 
MTKI       multi-targeted kinase inhibitor 
mTOR       mammalian target of Rapamycin 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide 
NGF       nerve growth factor 
NLR       NOD-like receptor 
NF-κB  nuclear factor kappa-light-chain-enhancer 
of activated B cells 
NOD  nucleotide-binding oligomerization 
domain-containing protein 
OMW       olive mill waste water 
PAMP       pathogen-associated molecular pattern 
PCR       polymerase chain reaction 
PlGF       placenta growth factor 
PI3K  phosphatidylinositol-4,5-bisphosphate 3-
kinase 
PLA2       phospholipase A2 
PRR       pattern recognition receptor 
QQ       quercetin quinone 
RANTES  regulated on activation, normal T cell 
expressed and secreted 
RLR  (RIG)-l-like receptor 
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RODW (polyphenol containing) rose oil 
distillation waste water 
ROI Region of Interest 
ROS       reactive oxygen species 
RTK       receptor tyrosine kinase 
TEAC       Trolox equivalent antioxidant capacity 
TGF-β       tumor growth factor beta 
TLR       Toll-like receptor 
TMB       3,3’,5,5’’-tetramethylbenzidine 
TNF-α       tumor necrosis factor alpha 
TRADD      TNF receptor-associated death domain 
UV       ultra violet 
VEGF       vascular endothelial growth factor 
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ii. Summary 
Liquid and solid agro-bio waste consists of complex molecules, and depicts the residue of 
which the nutritionally valuable portion has been removed. Depending on its origin and 
constitution, the waste fraction can be pernicious for the environment. In cases of further 
processing of these residues to value-added products, it is possible to reduce or even avoid 
waste fractions and thereby reach a sustainable way of production. This relatively modern 
approach is referred to as valorization and regarded an environmentally friendly practice since 
it expands the whole production process and thereby increases the degree of utilization. The 
raw material for valorization-accessible matter predominantly is generated as by-products in 
the agricultural cultivation and the food manufacturing industry, which depict the first two 
steps in the food supply chain. Realizing valorization procedures without affecting the quality 
of the original product requires detailed knowledge about the composition of the waste 
fraction and other characteristics to assess its fields of application. Therein, inadequate 
biological stability, potentially pathogenic nature, high water content, potential for rapid auto-
oxidation or a high level of enzymatic activity among others are limitation factors. Based on 
this concept, we investigated in pharmaceutical purposes of waste fractions of two different 
species: Moso bamboo (Phyllostachys edulis) and the Damask rose (Rosa damascena). In this 
context, particularly anti-inflammatory parameters, as well as wound-closure characteristics 
were of interest. 
The first part of this work is elucidating moso bamboo (Phyllostachys edulis)-derived 
compounds. Moso bamboo wood is utilized in many different sections of predominantly 
Chinese handicrafts (see section 2.1). Furthermore, bamboo sprouts are edible and pose an 
important ingredient in far eastern cuisine. Due to the plant’s fast growth of up to one meter 
per day, it depicts a potentially convenient resource for sustainable use of the wood. However, 
also tons of polyphenol containing leaves accrue during the harvest with no further 
pharmaceutical profit up-to-date. Since polyphenols are known for their multifaceted 
biological activities (see section 2.3), leaf extracts of Phyllostachys edulis were in the center 
of interest in terms of anti-inflammatory effects and wound closure activity on immortalized 
human keratinocytes and 3T3-swiss albino mouse fibroblasts. Therefore, levels of TNF-α-
induced cytokines like IL-6, IL-8 and VEGF under influence of the extracts and its major 
single polyphenol isoorientin, respectively, were analyzed. Wound closure characteristics 
were evaluated employing a computerized modification of the classical scratch assay 
involving time lapse microscopy. It could be demonstrated an improvement of wound closure 
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activity under influence of bamboo leaf extract (BLE) at moderate concentrations. At higher 
concentrations, BLE inhibited wound closure without impairing cell viability. The effect of 
isoorientin was comparable. Furthermore, BLE reduced TNF-α-induced VEGF and IL-8 
levels in HaCaT keratinocytes, isoorientin caused significant reduction of the cytokines in a 
dose-dependent manner. Generally, anti-inflammatory effects were determined moderately, 
since cytokine-levels of untreated cells could not be reached.  
The second and main part of the project analyzes biological activities of by-products of the 
Bulgarian rose oil production. Rose oil is basically used for both as a food ingredient and in 
cosmetic formulations. As the world’s main rose oil producer, Bulgaria cultivates the oil-
bearing rose Rosa damascena in the Rose Valley producing more than 2000kg of the essential 
oil per year. Each kilogram of flowers requires the four-fold quantity of water for further 
processing (Fig. 4). The multi-step water steam distillation is meticulous, however, about 
30.000 tons of polyphenol containing, bio-polluting waste water accumulate annually. This 
figure provides a first insight to recognize rose oil distillation waste water (RODW) as a 
substantial toxic factor. There is no effective post-production residue management in Bulgaria 
up-to-date.  
Purification of RODW resulted in a polyphenol depleted and a polyphenol enriched fraction 
[(RF20-(SP-207)], of which the latter one was split into four sub-fractions F(I)-F(IV) 
depending on the analytical spectrum of polyphenolic compounds. In a dose-dependent 
fashion, RF20-(SP-207) revealed anti-proliferative properties in human keratinocytes 
determined by ELISA-based bioassays. Time-lapse microscopy detected a significant 
impairment of cell migration under influence of RF20-(SP-207) and F(IV), respectively. TNF-
α induced VEGF-secretion was significantly reduced by both substances likewise. Since there 
is a close interplay between cell locomotion and inflammatory processes, the anti-
inflammatory properties of both RF20-(SP-207) and F(IV) were elucidated utilizing reverse 
transcriptase polymerase chain reaction (RT-PCR). RF20-(SP-207) and F(IV) significantly 
decreased the gene expression and cellular protein secretion of IL-1β, IL-6, IL-8, RANTES 
and MCP-1 and therefore, markedly modified inflammatory parameters in vitro.  
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iii. Zusammenfassung 
Flüssiger und fester Bio-Abfall besteht aus komplexen Verbindungen und stellt den 
Rückstand dar, von dem der nährstoffreiche Anteil abgetrennt wurde. Abhängig seines 
Ursprungs und seiner Zusammensetzung kann der Abfall einen umweltschädlichen Faktor 
darstellen. Im Falle einer Weiterverarbeitung dieser Rückstände zu aufgewerteten Produkten 
besteht die Möglichkeit Abfallanteile zu reduzieren oder gar zu vermeiden und dadurch eine 
nachhaltige Produktionsmethode zu erreichen. Dieser relativ moderne Ansatz ist auch als 
„valorization“ (deutsch: Aufwertung) bekannt und wird als umweltfreundliche Praxis 
betrachtet, da es den gesamten Produktionsprozess erweitert und damit den Nutzungsgrad 
erhöht. Die für die Aufwertung zugänglichen Rohstoffe werden hauptsächlich als 
Nebenprodukte in der Landwirtschaft und der Lebensmittelindustrie generiert, die die ersten 
beiden Stufen der Nahrungskette beschreiben. Das Umsetzen von Aufwertungstechniken ohne 
die Qualität des Originalprodukts zu beeinflussen setzt detaillierte Kenntnis der 
Zusammensetzung des Abfalls und andere Charakteristika voraus, um einen genauen 
Einsatzbereich des Nebenprodukts zu bestimmen. Dabei können eine verminderte biologische 
Stabilität, potentielle Pathogenität, ein hoher Wasseranteil, eine schnelle auto-Oxidation oder 
ein hohes Maß an enzymatischer Aktivität limitierende Faktoren sein. Auf diesem Konzept 
basierend haben wir pharmazeutische Verwendungen von Abfallprodukten von zwei 
verschiedenen Spezies untersucht: Moso Bambus (Phyllostachys edulis) und die Damaszener 
Rose (Rosa damascena). In diesem Kontext waren insbesondere antiinflammatorische 
Parameter, sowie Wundheilungscharakteristika von Interesse.  
Der erste Teil des Projekts beleuchtet Verbindungen aus dem Moso Bambus (Phyllostachys 
edulis). Moso Bambus hat zahlreiche Verwendungen hauptsächlich im chinesischen 
Handwerk (siehe Kapitel 2.1). Zudem stellen Bambussprossen als essbarer Bestandteil eine 
wichtige Zutat in der fernöstlichen Küche dar. Durch ihr schnelles Wachstum von bis zu 
einem Meter pro Tag repräsentiert die Pflanze eine potentiell geeignete Quelle einer 
nachhaltigen Nutzung ihres Holzes. Jedoch fallen während der Ernte auch Tonnen von 
polyphenol-haltigen Blättern an, die bis dato keinen weiteren pharmazeutischen Nutzen 
innehaben. Polyphenole hingegen sind bekannt für ihre facettenreichen Bioaktivitäten (siehe 
Kapitel 2.3). Insofern stellt dieser Teil der Arbeit Blätterextrakte hinsichtlich ihrer anti-
entzündlichen Aktivität auf immortalisierten humanen Keratinozyten und 3T3-swiss albino 
mouse Fibroblasten in den Mittelpunkt. Dafür wurden Spiegel von TNF-α-induzierten 
Zytokinen wie IL-6, IL-8 und VEGF unter Einfluss der Extrakte, bzw. seinem quantitativ 
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wichtigsten Polyphenol Isoorientin analysiert. Wundheilungscharakteristiken wurden unter 
Verwendung einer computerunterstützen Variante des klassischen „scratch assays“ mit 
Zeitrafferaufnahmen ermittelt. 
Es konnte eine Verbesserung der Wundheilungsaktivität unter Einfluss von Bambusblatt-
Extrakt (BLE) in moderaten Konzentrationen beobachtet werden. Im höheren 
Konzentrationsbereich inhibierte BLE den Wundschluss ohne die Zellviabilität zu 
beeinträchtigen. Der Effekt von Isoorientin war vergleichbar. Zudem reduzierte BLE TNF-α-
induzierte IL-8 Spiegel in HaCaT Keratinozyten dosisabhängig, Isoorientin zeigte in dieser 
Hinsicht Signifikanz. Im Allgemeinen wurden die anti-entzündlichen Effekte als moderat 
bestimmt, da Zytokin-Spiegel von unbehandelten Zellen nicht erreicht wurden. 
Der zweite Teil des Projekts analysiert biologische Aktivitäten von Nebenprodukten aus der 
bulgarischen Rosenölproduktion. Rosenöl wird hauptsächlich als Nahrungsbestandteil und in 
kosmetischen Formulierungen verwendet. Mit jährlich mehr als 2000kg des ätherischen Öls 
kultiviert Bulgarien als weltgrößter Rosenölproduzent die öl-bildende Rose Rosa damascena 
im Rosental. Jedes Kilogramm Blüten benötigt dabei die vierfache Menge an Wasser für den 
weiteren Produktionsablauf (Fig. 2). Die mehrstufige Wasserdampfdestillation wird akribisch 
durchgeführt; allerdings akkumulieren dabei jährlich über 30.000 Tonnen polyphenolhaltiger, 
umweltschädlicher flüssiger Abfall. Dieser Wert erlaubt einen ersten Einblick, um „rose oil 
distillation waste water“ (RODW) als einen substantiellen umweltschädlichen Faktor zu 
erkennen. Unserem Wissensstand nach existiert bis dato noch keine effektive 
Rückstandsverwertung in Bulgarien.  
Die Aufreinigung von RODW resultierte in einer Polyphenol-erschöpften und einer 
Polyphenol-angereicherten Fraktion [RF20-(SP-207)], von der letztere in vier Subfraktionen 
F(I)-F(IV) hinsichtlich ihres analytischen Spektrums an Polyphenol-Verbindungen 
aufgetrennt wurden. RF20-(SP-207) offenbarte dosisabhängig anti-proliferative Eigenschaften 
in humanen Keratinozyten, die auf Basis von ELISA Bio-Assays bestimmt wurden. 
Zeitraffer-Mikroskopie detektierte eine signifikante Beeinträchtigung von Zellmigration unter 
Einfluss von RF20-(SP-207), bzw. F(IV). TNF-α-induzierte VEGF-Sekretion zeigte sich 
signifikant reduziert durch beide Fraktionen gleichermaßen. Da ein enger Zusammenhang 
zwischen Zellbewegung und entzündlichen Prozessen besteht, wurden anti-entzündliche 
Eigenschaften von RF20-(SP-207) und F(IV) mittels Reverse Transkriptase Polymerase-
Kettenreaktion (RT-PCR) beleuchtet. RF20-(SP-207) und F(IV) verursachten dabei sowohl 
eine signifikant verminderte Genexpression, als auch eine reduzierte zelluläre 
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Proteinsekretion von IL-1β, IL-6, IL-8, RANTES und MCP-1 und modifizierten somit 
deutlich entzündungsspezifische Parameter in vitro. 
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1. Aim of the Work 
The world population is expected to grow from 6.7 billion in 2007 to 9.2 billion in 2050, 
which equals a rise of 37% [1]. Not only arable land, but also fresh water, air-quality and bio-
diversity among others are essential to life. With putting pressure on them, the importance of 
an effective global resource management rises. There exists no exclusive tool to ensure 
environmental sustainability – in this context, research & development is one of several key 
areas. 
Polyphenols as an important subgroup of phytochemicals are constituent parts in many natural 
resources and known for their multifaceted biological effects. To date, there exists a relatively 
broad data basis in the literature, which especially emphasizes on the antioxidant potential of 
the phytochemicals, but also on the strong metabolism when applied orally. This work 
analyzes polyphenol containing leaf extracts of Phyllostachys edulis and polyphenol-rich 
residues of rose oil distillation (Rosa damascena) on epidermal cells in terms of 
predominantly anti-inflammatory parameters, wound closure properties and inflammatory 
target gene expression using in vitro based settings.  
The starting point was to establish a modification of the classical scratch assay including time 
lapse pictures to visually trace cell locomotion and proliferation of keratinocytes and 
fibroblasts over a longer period. The results then were compared with findings elucidating 
quantitatively cell proliferation, cell death and cytokine expression levels such as VEGF, IL-
6, IL-8, RANTES and MCP-1. Finally, transcriptional activity of inflammatory genes was 
assessed. Thereby, it was possible to affirm the previous results by findings on a genetic level. 
Learning the major single compounds - isoorientin for Phyllostachys edulis and 
quercetin/ellagic acid/kaempferol for Rosa damascena - allowed to compare the observations 
with standard compounds and subsequently relate them to data in the literature.  
With emphasis on Rosa damascena, distinct effects of the tested compounds on epidermal cell 
lines endorse a potential projection for in vivo experiments considering a possible treatment 
option of e.g. hyperproliferation and/or chronic inflammation involved skin diseases. In this 
tenor, to overcome issues like an insufficient bioavailability of polyphenols, a topical form of 
application would be imaginable.  
Thereby, the work determines potentially pharmaceutical health benefits of two different 
types of natural products in the first instance, but also depicts a strategic approach to evaluate 
valorization options of originally process (agro-bio) waste. 
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[1]  Conféderation des industries agro-alimentaires de l'UE (CIAA), Managing 
Environmental Sustainability in the European Food & Drinks Industries, 2nd Edition 
http://www.fooddrinkeurope.eu/publication/managing-environmental-sustainability-
in-the-european-food-drink-industries/, 2008 (accessed 11.10.2016)
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2. Theoretical Background 
2.1. The Concept of Biomass Waste Valorization 
In every sort of industrial manufacturing, various types of waste accumulate. Regarding the 
food & drinks industry, especially organic waste mounts up. Agricultural raw material is the 
origin for all products of the food & drinks sector, but is also used for a long series of other 
branches like cosmetics and, of course pharmaceuticals among others. The partial overlapping 
of these branches is exemplified by neologisms like “cosmeceuticals” describing health 
benefits of a cosmetic or “foodaceuticals” addressing the well-being effect of certain 
foodstuff. In the following, it is not important which sector the final product is made for, but 
the composition of the waste fraction and its capacity for further benefit.  
 With 14,6% [1] of the market share within the European Union, the food & drink industry 
represents Europe’s largest manufacturing sector in terms of turnover and, therefore, exceeds 
other large-scale industries like the automobile, chemical, machinery and equipment sectors 
[5]. The food supply chain includes agriculture, food manufacturing, transport, retail & 
distribution, and household & food services.
 
Each step again splits up in numerous single players, expanding the system to a highly diverse 
network. For instance, among the 32 million jobs in the European food & drinks sector, 
farmers represent the majority with a portion of 36% [5]. Since farming systems depict the 
starting point of the food supply chain, agricultural raw materials pose the basic substance of 
these life-cycle stages, wherein tons of organic agro-bio waste accumulate annually. Liquid 
and solid agro-bio waste consists of complex molecules, of which the nutritionally valuable 
portion has been extracted for further processing, but which is still available for use. In this 
Fig. 1: The food supply chain starts with cultivation of natural resources and leads to the product for 
the end-consumer. Mainly in the agricultural sector and during food manufacturing, organic waste 
accumulates exemplified by the occurrence of waste water. 
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regard, the term “waste” can be irritating since it suggests a nugatory matter and should be 
replaced by the more neutral expression “by-product” if suitable for further usage. It 
accumulates predominantly during the agricultural cultivation, as well as in industrial 
processing in food manufacturing (Fig. 1). These are the two early stages in the food supply 
chain and depict the source of compounds that this work is dealing with. Due to the waste’s 
diversity in terms of aggregate state, complexity of compounds and sheer quantity, it’s impact 
affects economy, environment and society. In this regard, new strategies for proper energy 
use, greenhouse gas emissions, resource and waste management, water & wastewater 
management and packaging have emerged or is subject for improvement (e.g. by EU 
directives like ISO 14001 or the Sustainable Development Goals by the United Nations). 
In brief, waste reduction is driven by strategies leading to “environmental sustainability”, 
which requires an interaction of research, industry and policy makers of the food, cosmetic, 
pharmaceutical or agricultural sector, respectively. Regarding the modern consumerism 
lifestyle, it can be considered one of the major global challenges of the 21st century.  
Every stage in the food supply chain has its own environmental repercussion from the farmer 
to the consumer. For example, reducing transport routes to save fuel costs and emission, 
exchanging plastic wrappings to bio-degradable materials etc. are popular approaches that 
mostly apply to latter stages in the food chain. However, attaining sustainability demands a 
shared responsibility among all players involved, but begins with the cultivation of raw 
material. Oftentimes, environmentally friendly practices are inflicted with additional costs and 
thus, are opposed by financial interests of the producers. Achieving the primary objective -the 
avoidance of waste accumulation in food manufacturing- is extremely difficult [6], but the 
establishment of waste treatment strategies on the food manufacturing level is one chief 
aspect in approaching sustainability. In waste management, the most simplistic form is waste 
disposal. Briefly, there are three basic methods depending on the water content: incineration, 
anaerobic fermentation, and composting [6]. For example, if the water content is <50% 
(m/m), incineration is the only feasible option. Wastes with a content > >50% (m/m) are 
applied to anaerobic fermentation producing methane and carbon dioxide (biogas). However, 
these forms can be described as an “end-of-pipe-abatement” [6] with no significant reduction 
or recycling options, because they do not affect the production process per se. A more 
favorable and relatively modern approach is a “zero-point-discharge”, which implies the 
separation and selective recovery of compounds, and subsequent valorization of by-products 
to new value-added products [7]. The objective of this principle is multilayered such as 
harnessing natural resources, recycling of waste, et cetera. One example showing similarities 
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to the current situation of the Bulgarian rose oil production (see section 2.2) is the European 
olive oil production. As a main ingredient of the Mediterranean diet, virgin olive oil (from 
Olea europaea, also known as Olea sylvestris, Oleaceae) possesses a fairly positive image 
since this cuisine is associated with a lower risk of different forms of cancer, atherosclerosis, 
certain cardiovascular and neurodegenerative diseases [8-10]. Nevertheless, its industrial 
manufacturing generates problematic by-products in terms of environmental hazards. 
Typically, olive mill waste water (OMW) is a dark liquid due to its content of tannins and 
lignins (52.270-180.000 mg/L Pt/Co units) [11]. Its phenolic compounds and long-chain fatty 
acids are toxic to microorganisms and plants [12, 13]. Furthermore, phenols and sulfur 
dioxides generate emissions and thereby pollute the atmosphere [14]. Environmental toxicity, 
i.e. the organic load of waste waters can be specified by the chemical oxygen demand (COD), 
for instance. This parameter describes the total quantity of oxygen required for oxidation of 
organic compounds by a strong oxidizing reactant (e.g. potassium dichromate) under acidic 
conditions [15]. Usually, the value for COD is expressed in gram or milligram per liter. The 
literature reports COD-values for OMW between 40 and 220 g/L [13, 16, 17]. In this regard, 
it should be kept in mind that COD-values for OMW can vary, because of seasonal variances, 
different production methods, or different waste water treatments. As a comparison, the 
average COD of liquids processed by ordinary Swiss municipal waste water treatment plants 
is reported to be 155.6 mg/L before treatment [18], thus, incontrovertibly lower. Mainly in 
Greece, OMW is disposed of in specific evaporation ponds. There, the waste water transforms 
into an acidic sludge-type of liquid without further processing. This technique already poses a 
respectable achievement in terms of environmental protection, since OMW has been illegally 
disposed of on soil or in rivers for many years leading to fatal consequences for the 
environment in the Mediterranean area [16]. The major immediate drawbacks of evaporation 
pond disposals, however, are the occurrence of bad odor, soil infiltration and insect 
proliferation. This disposal method generally does not support the idea of a sustainable 
production. Studies about the pharmaceutical benefit of OMW among other valorization 
approaches exist (e.g. [19]). Nonetheless, no specific marketed product has emerged out of 
OMW, nor has an environmentally sound and cheap strategy for detoxification been 
established. Besides the liquid waste fraction, also (semi-)solid pomace accrues. Contrary to 
OMW, the pomace fraction is further utilized in forms such as soap, wood, biodiesel 
production, cosmetics and dietary products [20]. In terms of trade chains, the olive oil 
manufacturers typically resell accumulated olive cake to pomace treatment companies for 
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further processing. Therefore, the solid waste poses one example for a valorized, marketable 
by-product in agro-industrial olive oil production. 
Tab. 1 gives an overview of major branches of the food & drink industry including their chief 
waste fractions, for which valorization options are not exhausted yet.  
Branch Type of waste 
grain products bran, middlings, broken grains, seeds, 
shells, husks, fine dust, chaff, straw, ergot, 
brown rice waste, rice bran, rice flour, 
seedlings from malt, malt dust, grain 
separator waste 
noodles dough waste, eggshells 
potato processing industry potato peels 
coffee roaster silverskins 
sugar molasses, beet pulp, beet leaves and stems, 
carbonation sludge 
dairy processing industry whey, cheese residue, waste from milk 
production 
meat industry slaughterhouse waste 
egg products eggshells 
beer production malt dust, spent grains, break material, 
yeast, kieselguhr sludge 
wine cellars pomace, clarification sediment, yeast 
sediment 
However, the main complications regarding the valorization of agro-bio waste is a result of 
for example the inadequate biological stability, potentially pathogenic nature, high water 
content, potential for rapid auto-oxidation and high level of enzymatic activity among others 
[4]. This work is focusing on the examination of biomass waste-derived compounds for 
pharmaceutical purposes, which depicts one further approach of waste recovery.   
Tab. 1: Overview of typical branches of the food industry producing various types of waste. Not for every 
sort of waste, valorization options have been assessed, which depend on biological stability, pathogenic nature, 
water content, enzymatic activity among others. Data adopted from [4]. 
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2.2. Ecological Aspects of the Chinese Bamboo Cultivation and the Bulgarian Rose Oil 
Production  
One of the natural resources this work has been used materials of is “bamboo”. The term 
commonly describes a member of a taxonomic group of woody grasses (Poaceae), which 
belongs to the subfamily Bambusoideae [21]. More than 1300 species occur across the 
tropical and subtropical belt; except for Europe and Antarctica, bamboo is native to every 
continent [22]. China’s bamboo population -that is referred to in the following- accounts for 
about 300 species growing on a land area of approximately 45.000 km2 (Switzerland total area 
approximately 41.000 km2), which relates to 2.8 % of the country’s total forest area [23]. 
Covering 70 % of this forest area, moso bamboo (Phyllostachys edulis, also known as 
Phyllostachys pubescens) is the most prominent species, which primarily grows in the south 
of China. 
 The graminaceous plant shows an above-average 
fast growth (up to one meter per day; Fig. 2) and 
can be considered notably versatile; over 40 % of 
the world’s population utilize bamboo every day 
[24]. If used properly, bamboo forests can be an 
inexhaustible, sustainable source of raw material 
[25]. After cutting the culms, no replanting is 
needed. Due to its superior tensile strength, it is 
mostly used for handicrafts like furniture, paper, 
textiles, plywood boards and building material [24]. 
It is also harvested for its edible shoots and - in 
light of the climate change - bamboo gained 
considerable importance in carbon cycling [26, 27]. 
However, due to a lack of knowledge and 
equipment of the local farmers, forest management 
and production yield is still limited in many cases 
[28]. According to Zhuang et al. [21], the biomass 
proportion of leaves and twigs of an average moso bamboo tree accounts to 14 ± 4 %. 
Looking at the vast land areas of Chinese bamboo forests and the demanding needs of the 
world’s population, bamboo leaves pose a by-product that accrues in tons. In the years 1990, 
2000, and 2005, China’s stock of bamboo resources was reported to be 96, 144, and 164 
Fig. 2: Forest of Moso bamboo 
(Phyllostachys edulis). Picture adopted from 
http://bamboogarden.com  
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million tons, respectively [28]. As an organic material, the leaves of course do not pose an 
environmental hazard per se since the fall of leaves is part of the natural production cycle. 
Thus, an organic waste disposal in terms of composting would be possible, but this does not 
enable any recycling or recovering options and thus, does not support the idea of resource 
sustainability.  
Nevertheless, the leaves have gained considerable attention in pharmaceutical research in 
recent years. Besides being a food source for cattle and wildlife animals [22], the leaves 
contain bio-active molecules (polyphenols among others) of potentially pharmaceutical value. 
These properties allow for various valorization options, of which further elucidation is 
needed. In fact, bamboo has attracted curiosity of western companies of late (e.g. Organic 
Bamboo Industries AG, St. Gallen, Switzerland), which focus on beauty- and health products 
made of bamboo leaf extracts.  
With respect to the environmental issues from olive oil fabrication in Mediterranean 
countries, the situation of the industrial rose oil production in Bulgaria is comparable. For 
centuries, Bulgaria cultivates the oil-bearing Rosa damascena Mill. (Rosaceae) in the Valley 
of Roses (“Rozovata Dolina”) near the city 
of Kazanlak (Fig. 3). Because of favorable 
climate conditions and centuries of 
experience, the rose oil (also known as rose 
otto or rose attar) is reckoned a product of 
higher quality and value compared to other 
producing countries. Since 2014, the 
European commission includes the 
essential oil in the list of protected 
geographical indications and designations 
of origin for agricultural product and 
foodstuffs under the name of “Bulgarsko rozovo maslo”. The annual global consumption of 
pure rose otto is around 3000-4500 kg; of this, 80-90 % is produced by Bulgaria and Turkey 
[29]. In 2008, one kilogram of rose oil was sold at a price of 4600 €. For this reason, the 
industry has a respectable social impact as the product is mostly exported and, thus, supports 
local economy, tourism, research & development, generates jobs and overall creates a positive 
reputation of the nation. Nevertheless, its production method is afflicted with the 
accumulation of polyphenol containing rose oil distillation waste water (RODW).  
Fig. 3: Rose field in the Valley of Roses, Bulgaria. 
(Rosa damascena). Picture adopted from 
http://rosecosmetic.net  
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In brief, rose petals are typically harvested from May to June between sunrise and noon, when 
the oil content in the flower is at a maximum. Immediately after, the blossoms are put in the 
hydro-distillation still, where they are boiled for about two hours to release the essential oil. 
The water steam distillation of rose oil produces a valuable by-product called rose water next 
to the essential oil. The hydrosol contains 2-phenylethanol among others, which is partly 
water soluble [30] and mostly responsible for the distinct rose scent, because it is soluble in 
the essential oil and poses a major compound. By repeating distillation cycles manifold, 2-
phenylethanol is transferred from the aqueous to the lipid phase and thereby the yield of the 
rose oil increases. Within this process, polyphenols that were originally contained by the 
flower, are now passed over to the waste water, of which large volumes accrue. 
As an estimation, to obtain ten grams of the attar, about 100 kg of rose petals are necessary 
[31]. Depending on the size of the distillers, four to eight liters of water per kilogram rose 
material is added. In 2008, Bulgaria produced about 2000 kg of pure rose oil [29]. As a total, 
more than 30.000 tons of liquid waste accumulate per year, which provides a first insight to 
recognize RODW as a serious, substantial pollution factor.  
The meticulous multi-distillation cycle process is referred to as cohobation [29] and describes 
the repeated return of the separated condensate to the still during the actual distillation 
process. This is necessary to increase the yield of the essential oil and enrich the hydrosol 
with intensive smelling compounds like 2-phenylethanol. Furthermore, this procedure results 
in relatively high levels of dissolved, non-volatile polyphenols in the remaining RODW, 
which has commonly been regarded as a low-quality by-product that is all too often disposed 
inappropriately. Fig. 4 shows a flow chart of the waste fractions accruing during the 
production process. Therein, only fractions out of the liquid residues were of interest.  
Fig. 4: Flow chart of the Bulgarian rose 
oil production including the liquid waste 
accumulation and compound purification. 
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Looking at the environmental toxicity of RODW, literature is scarce. Avsar et al. [32] reports 
a COD-value of 9500 mg/L, which refers to the rose attar production in Isparta, Turkey, but 
can be conjectured the same for the Valley of Roses. Up until today, there is no effective post-
production waste water management in Bulgaria, when looking at the rose oil distillation. 
However, based on a sustainable way of resource utilization, RODW as a by-product could 
potentially pose an interesting valorization option for pharmaceutical purposes, which will be 
specified in the following.  
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2.3. Major Polyphenolic Compounds in Rosa damascena 
One important aspect of waste water management is the analysis of its composition. Since 
polyphenols represent the pharmacologically relevant constituents herein, a short introduction 
shall be given.  
Polyphenols describe a highly diverse group of predominantly natural, organic compounds 
encompassing simple monomers, oligomers to complex polymers [33]. Over 8000 different 
structures are identified, about half of them belong to the sub-group of flavonoids. There exist 
polyphenols such as anthocyanins, lignins or stilbenes that count as secondary metabolites, 
which are synthesized in planta as a defense strategy to deter herbivores [34], or in the case of 
flavonols and flavones act as UV filters [35]. Also, there are polyphenols, especially 
flavonoids, which attract organisms intending pollination or seed dispersal for survival and 
propagation. As dietary compounds, they mostly determine organoleptic properties in 
foodstuff and beverages. Despite sharing a common phenolic structure, they show fairly 
strong differences in their physicochemical properties. Particularly in case of the flavonoids, 
one of their most prominent feature is their antioxidant quality, which has been widely 
elucidated by the literature (e.g. [36-39]). What is more, bio-activities such as anti-histamine 
[40], anti-bacterial [41], anti-viral [42] and enzyme-inhibitory [43-45] among others have 
been described.  
Encompassing more than 300 different chemical structures in total [29], both Rusanov [46] 
and Schieber et al. [47] have detected quercetin, kaempferol and their derivatives as prime 
phenolic constituents in RODW based on HPLC-ELSD and HPLC-LC/MS, respectively. 
These outcomes are specified through HPLC-ELSD guided analysis by Solimine et al. [45], 
who examined the substance utilized in the present work and detected quercetin, kaempferol 
and ellagic acid as the major constituents.  
 Quercetin and kaempferol are members of the flavonols, a sub-
group of flavonoids (Fig. 6). The flavonol’s backbone is a C6-
C3-C6 structure (flavan; Fig. 5) in which the C6-units are of 
phenolic nature, while the C3-body as a chromane ring is 
subject to hydroxylation. With regards to quercetin and 
kaempferol, the B-ring is attached to the C2-position of the C-
ring. Moreover, quercetin possesses two hydroxyl groups 
attached to the B-ring (C4’ and C5’), whereas kaempferol has only one (C4’).  
Fig. 5: C6-C3-C6 structure 
(flavan). 
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In planta, most of the polyphenols exist as glycosides, giving quercetin and kaempferol a 
variety of more than 279 and 347 substitution patterns 
[35].  
 Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is 
considered one of the most effective reactive oxygen 
species (ROS)-scavengers among all flavonoids [48], as 
well as a potent metal ion chelator. Anti-inflammatory 
effects in the form of symptom alleviation were 
observed using quercetin as treatment against chronic 
prostatitis [49]. Begum and Terao [50] reported about a 
quercetin-protective effect against aqueous cigarette-tar extract induced impairment of 
erythrocyte deformability. However, the variety of physiologic effects by quercetin also bears 
some unfavorable outcomes such as the quercetin paradox described by Boots et al. [51]. That 
is while scavenging free radicals formed by hydrogen peroxide as DNA-strand protection, 
quercetin converts into its oxidized form, primarily a semiquinone radical, which immediately 
forms to quercetin quinone (QQ) in a second reaction. QQ is thiol-reactive manifested by a 
preferential interaction with glutathione (GSH) ultimately leading to an increase in cytosolic 
calcium level and lactate dehydrogenase (LDH) leakage. Nonetheless, in 1999 the 
International Agency for Research on Cancer (IARC) has declared quercetin as non-
carcinogen for humans [52].  
Kaempferol (3,4',5,7-tetrahydroxyflavone) resembles the pharmacologic profile of quercetin 
in many aspects due to its structural similarity. However, the antioxidant potential, for 
instance, is lower because of the missing catechol structure in the B-ring. This structure-
activity relationship is illustrated in vitro by the TEAC (Trolox equivalent antioxidant 
capacity) established by Rice-Evans et al. [38]. In brief, 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox) is a water-soluble vitamin E derivative, which 
scavenges 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS∙+), a preformed 
radical cation chromophore, at pH 7.4. The TEAC is defined as the concentration of Trolox 
solution necessary to scavenge the same quantity of ABTS∙+ like the antioxidant of interest in 
a concentration of 1 mM. Thus, the value permits a comparison of different antioxidants by 
expressing their scavenging potential and is typically used to characterize antioxidant 
capacities of polyphenol-containing solutions. For quercetin, a TEAC of 4.7 mM is reported, 
while kaempferol accounts for 1.34 mM [37]. 
Fig. 6: basic structure of flavonols. 
Quercetin R1=H, R2=OH, R3=OH 
Kaempferol R1=H, R2=OH, R3=H 
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Pointing out the flavonol’s beneficial effects on inflammation, 
kaempferol has been precisely reviewed by Devi et al. [53]. 
Ellagic acid (2,3,7,8-Tetrahydroxychromeno[5,4,3-
cde]chromene-5,10-dione)  is a gallic acid dimer, and 
therefore does not belong to the group of flavonoids (Fig. 7). 
In planta, ellagic acid exists in form of hydrolyzable tannins. 
Ellagitannins are esters of glucose and contribute to the 
structure of the cell wall and -membrane [54]. Naturally, 
ellagic acid (EA) occurs predominantly in nuts, berry fruits 
such as strawberries or raspberries, but, interestingly, also in distilled beverages like several 
types of whiskies, brandies and rum [55]. In the literature, ellagic acid oftentimes is associated 
with anticarcinogenic properties. Zhang et al. [56] suggests a pathway modulation of the 
tobacco specific carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone reduction by 
ellagic acid-dependent inhibition of constitutive CYP-enzymes. Vanella et al. [57] 
hypothesize EA influencing apoptosis, for example by modifying the expression levels of 
proteins like TGF-β or IL-6, which are strongly involved in tumor growth and cell 
invasiveness of prostate cancer. In this context, numerous citations could be listed. However, 
besides anti-carcinogenic or -mutagenic effects, also subcellular pathway modulations are 
reported. Edderkaoui et al. [58] describe EA to stimulate apoptosis and inhibit proliferation of 
human pancreatic adenocarcinoma cells, an activation of the mitochondrial death pathway 
triggered by the release of cytochrome C and caspase-3 activation and a decreased activity of 
the transcription factor NF-κB. In higher concentrations, EA was found to inhibit proliferation 
of ovarian carcinoma in ES-2 and PA-1 cells by arresting both cell lines in the G1-phase.  
In contrast to the reportedly antioxidant activity of flavonoids and the physiological outcomes 
accordingly, ellagic acid has multifaceted effects on cells. Its numerously recited 
anticarcinogenic character is a result of direct (e.g. G1-phase arrest) and indirect influence 
(subcellular pathway modulation) on the cell cycle, as well as on cell death determinants such 
as caspase-3 for instance. Above all, it must be kept in mind that most of these studies were 
conducted under in vitro-conditions. The question of the correlation between these data and 
studies in humans remains. One reason for this is, because in vivo-studies in humans are 
difficult to conduct due to obstacles such as environmental factors, protein bonding, colonic 
microflora, low bioavailability, complications in detection methods, rapidity, extent of 
metabolism and many others. However, few studies dealing with polyphenols used on animal 
models exist, for example by Frei and Higdon [59], who referred to the antioxidant activity of 
Fig. 7: ellagic acid is a dimer of 
gallic acid. 
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tea polyphenols in animal models. Therein, they describe plasma and intracellular 
concentrations of tea catechins and polyphenols being 100 to 1000 times lower than 
physiological antioxidants like ascorbate, urate and GSH, which alludes to bioavailability 
issues of polyphenols. In contrast, oral feeding of a polyphenol-rich fraction of green tea to 
hairless SKH-1 mice with subsequent exposition to UVB radiation resulted in a lower COX-
activity. This outcome was illustrated by a prevention of cutaneous edema and depletion of 
the antioxidant-defense system in epidermis demonstrated by Agarwal et al. [60]. Similarly, 
the uptake of green tea-containing drinking water stopped ethanol-induced GSH-level 
decrease in male rat livers [61]. A study addressing human plasma concentrations after 
consumption of epicatechin gallate, epigallocatechin, or epigallocatechin gallate has been 
executed by Van Amelsvoort et al. [62]. They found significant differences in the 
pharmacokinetic behavior of these substances among ten healthy volunteers and could not 
confirm a significant, stable increase of plasma antioxidant capacity. Naumov et al. [63] tested 
a formulation containing dihydroquercetin on burned rat skin and uncovered inhibition of 
factors inducing development of necrosis, tissue ischaemia, wound infections as well as 
facilitation of tissue regeneration. Shubina and Shatalin [64] tested various dihydroquercetin 
formulations on chemically burned rat skin and found protective properties including the re-
establishment of intact hair follicles 
and sebaceous glands. Especially anti-
inflammatory, immune modulating 
and anti-microbial functions among 
others have been ascribed to quercetin 
and ellagic acid by Dzialo et al. [3] 
reviewing plant phenolics in 
prevention of skin disorders (Fig. 8). 
Thus, disagreements exist in terms of 
bioavailability, bioactivity in target 
tissues and metabolism of dietary 
polyphenols, but it can be concluded 
that skin recovery effects by 
polyphenols have been observed. 
One reason for the differences 
between animal and human studies, for instance, could be animals generally receiving higher 
doses per kg bodyweight. Moreover, humans show wide genetic variations in response to 
Fig. 8: Pharmacological properties of polyphenols. Figure 
adopted from Dzialo et al. [8]. 
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oxidative stress and cancer, which can mask changes of biomarkers to some extent [59]. For 
reviews addressing this issue thoroughly, please refer to [65-67]. 
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2.4. Inflammation 
The previous chapter describes polyphenols, especially quercetin and ellagic acid as 
inflammation modulating substances. Since these compounds are key ingredients in Rosa 
damascena, and the fact that pro-inflammatory parameters play a crucial role in this work, it 
is important to outline the major processes during these types of skin insults.  
The term “inflammation” is commonly used for the complex biological response of the 
mammalian organism triggered by any type of bodily insult such as pathogenic signals (e.g. 
UV- or X-ray irradiation, heat), abrupt anoxia, noxious chemicals (e.g. H2O2), infectious 
agents (viruses, bacteria, prions, fungi) or mechanical tissue damage. Regarding the surface of 
the body, the onset of the inflammatory response is clinically characterized by calor (heat; 
describing the increase of temperature in the affected tissue due to vasodilatation and thereby 
increased blood flow), dolor (pain), rubor (redness; evoked by the upregulated blood supply), 
tumor (swelling; body fluid accumulates because of increased tissue permeability) and 
sometimes functio laesia (loss of function; immobility) [68]. Since these symptoms are 
generic, it is apparent that the inflammatory response usually begins with the immediate 
activation of the innate immune system.  
In brief, the inflammatory stimulus is typically detected by sensor cells such as macrophages, 
granulocytes, mast cells or dendritic cells through activation of innate pattern recognition 
receptors (PRR). According to Rajamuthiah and Mylonakis [69], PRR`s can be divided into 
four subgroups: Toll-like receptors (TLR’s), C-type lectin receptors (CLR’s), (RIG)-l-like 
receptors (RLR’s) and NOD-like receptors (NLR’s). They occur either at trans-membrane 
locations (TLR’s, CLR’s) or in the cytosol (RLR’s, NLR’s). These receptors individually 
recognize foreign pathogen-associated molecular patterns (PAMP’s), which are mostly 
conserved, repetitive structures and unique to the specific stimulus (e.g. surface patterns of the 
gram-positive or gram-negative bacteria cell wall). Furthermore, PRR’s can detect damage-
associated molecular patterns (DAMP’s), that is body’s own cellular degradation products. 
Once activated, the sensor cells either act directly neutralizing the noxious agent (e.g. by 
phagocytosis) or indirectly by the release of mediators like cytokines and chemokines, which 
themselves entice other immune cells to the inflammatory site (chemotaxis) and thereby 
propagating the immune response [70]. Adjacent processes are governed by the adaptive 
immune system, which are highly specific depending on the insult and are directed to a long-
lasting protection. Whereas the response of the innate immune system lasts a few days at 
most, the acquired part is active for days to weeks, because the organism creates memory T 
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and B cells to shield the body from a repeating insult. In any case, the adaptive immune 
response can only be initiated by the innate immune cascade [71]. 
The innate immune response takes effect minutes after injury or infection, but is limited in its 
effectivity due to a lack of specificity. From an evolutionary perspective, a self-limiting acute 
inflammation displays the first-line response of the organism and is crucial for survival. That 
is, considering a four to seven days-delay before the sophisticated adaptive immune system 
takes effect, it is of utmost importance for the organism to control the insult during this 
period. Without the tightly regulated cascade, the organism would eventually perish because 
of tissue disruption, sepsis etc.  
 
Cytokines, Chemokines, Interleukins 
To a small degree, the innate immune system can regulate its response. Depending on which 
PRR’s are specifically activated, a certain subset of mediators is secreted by the sensor cells. 
One subgroup is represented by small proteins of about 25 kDa called cytokines. Their 
effects, which are briefly specified in the subchapters accordingly, can be autocrine, paracrine 
or -depending on their half-life in the blood and their bioavailability- endocrine. Generally, 
these effects are manifested in profound influence on leukocyte migration and function, 
hematopoietic cell numbers, temperature regulation, acute phase responses, tissue remodeling 
and cell survival. The way of production is a multi-step process and oftentimes happens by 
the activation of the key integrator of cell signaling and transcription factor NF-кB [72]. 
Using the example of IL-1β production by TLR activation, the cascade is illustrated in detail 
by Takeda and Akira [73]. Keestra-Gounder et al. [74] describe the NOD1 and NOD2 
triggered IL-6 stimulation that also happens via the NF-κB cell signaling pathway. 
Cytokines, which additionally attract and direct effector cells (chemotaxis) to the 
inflammatory site, are called chemokines (∼8-14 kDa). The name has been introduced at the 
“Third International Symposium on Chemotactic Cytokines”, which took place in Baden-bei-
Wien, Austria, in 1992. The first and best characterized member of these type of proteins is 
CXCL8, better known by the name of IL-8. Responding cells are predominantly leukocytes, 
which in turn activate monocytes, neutrophils and other blood-derived effector cells. 
Furthermore, chemokines influence leukocytes of the adaptive immune system, too [70]. 
Compared to the variety of cytokines, there exists a relatively little number of receptors - 
showing a certain receptor promiscuity. A single chemokine can bind to several receptors, 
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while a single receptor can transduce signals to many chemokines. Mechanistically, their 
chemotactic effect is mediated by seven trans-membrane-domain receptors, which are part of 
the G-protein-coupled receptor (GPCR) superfamily [75]. Thus, their functional redundancy 
(see [75], Table 1) delivers a great beneficence in controlling the course of an inflammation. 
Structurally, chemokines can be divided into two major groups: the CC-chemokines present 
two vicinal cysteines, while in CXC-chemokines, the two cysteines are separated by one 
amino acid. Accordingly, CC-chemokines bind to CC-receptors, whereof nine different are 
known. CXC-chemokines on the contrary bind to CXC-receptors, whereof six are known up-
to-date.  
The term “interleukin” was originally introduced to simplify the nomenclature of proteins that 
either are secreted by or act on leukocytes. However, with progressing research, the 
complexity and number of this group of proteins increased rapidly. Although the 
“interleukin”-nomenclature is still popular, a structure-related designation (e.g. CXCL8 
instead of IL-8) is considered more precise.  
Generally, cytokines and chemokines function as potent immune modulators. They can be 
regarded as the interface between the innate and the adaptive immune system, since they take 
influence on them likewise. Just like in every form of communication, it takes a sender, a 
message and a recipient. Looking at this allegory, the activation of PRR´s poses as the sender 
that posts an encrypted message in form of the cytokine, which must be delivered to a cell 
containing the decrypter in form of the receptor transducing the signal [76]. In summary, four 
characteristic key features can be observed, that apply to almost the entire cytokine network: 
1. pleiotropy (most cytokines cause several effects); 2. redundancy (one effect is caused by 
many different cytokines); 3. potency (most cytokines act in the nanomolar to femtomolar 
range); 4. action as part of a highly-regulated cascade. 
 
Tumor Necrosis Factor Alpha 
Originally introduced by the name of “cachectin” [77], tumor necrosis factor alpha (TNF-α) is 
a key mediator in the inflammatory response and secreted by many different cell types such as 
monocytes, macrophages, B/T cells, and fibroblasts. As a member of the acute-phase-
proteins, the protein of 17 kDa can bind to two different receptors: TNF receptor type 1 (TNF-
R1) and TNF receptor type 2 (TNF-R2) posing the TNF receptor superfamily. While the 
transduced signals of TNF-R2 are yet to be fully understood, TNF-R1 has been further 
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elucidated [78]. Predominantly, the receptor binding increases the gene expression of lots of 
pro-inflammatory genes by activation of NF-κB and thereby decisively influence the course 
of an inflammatory response. In addition, in some transformed cell types, the TNFR1-
transduced signal realizes apoptosis and/or necrosis, e.g. by activation of caspase-8 through 
the adapter protein TNF receptor-associated death domain (TRADD) in the apoptotic 
pathway. As a third major characteristic, TNF-α can activate the mitogen-activated protein 
kinase (MAPK) cascades [79, 80], that is the Jun N-terminal kinase (JNK), the p38 MAP 
kinase [81] and to a smaller extend the extracellular signal-regulated kinases (ERK).  
Its pleiotropy makes TNF-α a crucial factor in the regulation of inflammation, autoimmunity 
and neurodegeneration involved diseases such as rheumatoid arthritis, multiple sclerosis, 
Parkinson’s disease, and Alzheimer’s disease [82, 83]. Therefore, TNF-α has become one 
attractive target for drug development, for example in form of the biopharmaceutical 
Etanercept. 
 
Interleukin-1 beta 
One synonym of interleukin-1 beta (IL-1β) is “leukocytic pyrogen”, which is presumably the 
first physiologic action it was related to. Its purification was originally described by Dinarello 
et al. in 1977 [84]. The interleukin-1 superfamily of ligands and receptors is probably 
associated with acute and chronic inflammation more than any other mediator in this context 
and fundamental for the innate immune system [85]. IL-1β (17.5 kDa) is preceded by its 
immature form pro-IL-1β (31 kDa), which must be cleaved intracellular by Interleukin-1 
Converting Enzyme (ICE, also known as caspase-1) or extracellular by neutrophilic proteases 
to become responsive for the interleukin-1 receptor (IL-1R). Interestingly, the cytosolic 
segment of the ligand binding chain IL-1 receptor type 1 (IL-1RI) shares a homologous 
domain with the Toll protein in Drosophila. This explains some functional similarity of the 
two molecules in terms of TLR-activation and thus, can be considered the link to the 
nonspecific host defense in response to pathogenic invaders [85]. Pro-IL-1β is produced by 
macrophages and epithelial cells after exposition to PAMPs and DAMPs [86] (for a detailed 
review of the mechanism, see Takeda and Akira [73]). Downstream cytoplasmic signaling 
pathways modulate the expression of several genes including IL-1β itself, TNF-α, matrix 
metalloproteases (MMP’s), nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), 
phospholipase A2 (PLA2) and others [87]. Surprisingly, despite its low specificity, IL-1β is 
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capable to trigger antigen-specific responses of murine T cells demonstrated by Rosenwasser 
et al. [88] and thereby, affecting the acquired immune system, too. However, IL-1β binds 
with greater affinity to the highly-conserved IL-1 receptor type 2 (IL-1RII). This receptor is 
mostly expressed on the cell surface of macrophages and B cells and thereby, poses a decoy 
receptor. The fact that glucocorticoids for instance induce the production of IL-1RII could 
partly explain the receptor’s anti-inflammatory properties [85]. Studies suggest a relation 
between the level of IL-1β, IL-1 receptor antagonist (IL-1Ra) and IL-1RII in relation to 
disease severity. Therefore, IL-1β has also attracted the focus of drug development. One 
successful model in this regard is the biopharmaceutical anakinra, which is a recombinant 
version of the IL-1 Receptor antagonist (IL-1Ra) used in the treatment specifically for 
rheumatoid arthritis. It competitively binds to the IL-1RI (same affinity like IL-1β), but less to 
IL-1RII (compared to IL-1β) for which reason its potential is limited and considered inferior 
to TNF-α blockers [87, 89, 90]. Thus, research now tends to focus on blocking directly with 
higher inhibitory potency such as canakinumab (for detailed review, see [91, 92]). 
 
Interleukin-8 
Before establishing the general designation “Interleukin-8” (IL-8; also known by the 
systematic designation CXCL8), in various publications the protein was independently 
described as “neutrophil-activating factor” [93], “monocyte-derived neutrophil-activating 
peptide” [94], “monocyte-derived neutrophil chemotactic factor” [95] and others. Its 
activating properties in terms of neutrophil migration led to the assumption that it was 
neutrophil-specific. However, it subsequently was revealed that CXCL8 is actually produced 
by a diversity of cell types such as monocytes [93, 94, 96], T cells [97, 98], macrophages, 
keratinocytes [99], fibroblasts [100], epithelial cells, hepatocytes, synovial cells [101] and 
endothelial cells [102, 103]. CXCL8 is one out of eight members of the CXCL8 family, who 
all have an ELR (glutamic acid-leucine-arginine) motif in their structure in common [104, 
105]. Moreover, the family shares the same receptors, that is CXCR1 and CXCR2, which are 
G-protein coupled and have different selectivity for their ligands making them interesting 
therapeutic targets for inflammation-related diseases (atherosclerosis, cancer, inflammatory 
bowel disease, ischemia, asthma, cystic fibrosis, multiple sclerosis, psoriasis, rheumatoid 
arthritis and many others). According to Wolf et al. [106], CXCL8 possesses a relative 
selectivity to CXCR1. However, both receptors are also produced by a great variety of cell 
types including keratinocytes [107], fibroblasts [108], endothelial cells [109], hepatocytes 
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[110] and others illustrating the ubiquity of the CXCL8 family. From a physiological 
perspective, CXCL8 has not only been related to chemotactic actions, but also to angiogenesis 
in human umbilical vein endothelial cells (HUVEC) [111], lung cancer cells [112] or L1.2 
transfectants [113]. In summary, it can be said that in vitro-designed studies accentuate 
chemotactic effects of CXCL8, while in vivo-based studies prevalently emphasize on its pro-
angiogenetic character, especially in diseases, which are related to chronic inflammation.  
 
Monocyte Chemotactic Protein-1 
In contrast to CXCL8, monocyte chemoattractant protein-1 (MCP-1/CCL2) does not belong 
to the CXC family, but to the CC family. Therefore, it does not share an ELR motif in its 
structure. For this reason, CCL2 predominantly chemo-attracts monocytes, memory T cells, 
and dendritic cells [114, 115], but poorly attracts neutrophils [116]. CCL2 was the first CC 
chemokine discovered in humans and originally isolated from mouse 3T3 fibroblasts [117], 
then soon thereafter from tumor cell lines [118, 119]. Triggers for the production of this 
protein in various cell types (e.g. epithelial, endothelial, smooth muscle, fibroblasts, 
astrocytes, monocytes, and microglial cells [120-122]), are detrimental factors like oxidative 
stress or other cytokines and growth factors such as platelet-derived growth factor (PDGF), 
interleukins IL-1 and IL-4, TNF-α, vascular endothelial growth factor (VEGF), bacterial 
lipopolysaccharide, and interferon γ (IF-γ) [123, 124]. CCL2 builds an axis with its prime 
receptor CCR2 expressed on the cell surface. Given the fact that this receptor also belongs to 
the G protein-coupled receptor superfamily, it is not a surprise that CCL2-elicited effects are 
pleiotropic [125] including a rise in intracellular calcium, induction of respiratory burst and 
gene expression [126, 127]. Because of the specific effects on mononuclear cell migration, it 
was suggested that CCL2 is a significant regulator of inflammatory diseases. In fact, this 
could be verified by several studies using genetically deficient mice, antibody- or inhibitor-
mediated neutralization in mice (see e.g. [128-130]), and epidemiological studies in humans. 
The most extensive data in this regard probably exists for medical conditions such as 
atherosclerosis and multiple sclerosis. One aspect of the pathogenesis of arteriosclerotic 
vascular disease is described by monocytes penetrating subendothelial layers where they 
differentiate to macrophages, which chronically uptake cholesterol and become adherent to 
the arterial cell wall [131] resulting in the mature atherosclerotic plaque. CCL2 in this context 
is one major constituent to attract monocytes and therefore a decisive factor for the onset of 
the cascade [132]. Thus, a reduction of the number of circulating monocytes are associated 
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with the amelioration of the disease in general. In fact, this hypothesis could be validated by a 
number of studies using CCL2- or CCR2-deficient mice (e.g. see [128, 133, 134]).  
 
Vascular Endothelial Growth Factor 
The vascular endothelial growth factor (VEGF) belongs to a family of seven homologs 
including the placenta growth factor (PIGF) 1 and 2, VEGF-B, VEGF-C and VEGF-D [135, 
136]. Accordingly, there are three different receptors VEGFR-1, VEGFR-2 and VEGFR-3 
with different ligand-binding affinities that belong to the receptor tyrosine kinases (RTK). 
However, the prototype among them is VEGF-A, which herein is referred to as VEGF below. 
Looking at its original designation “vascular permeability factor”, two major attributes of this 
signal protein are apparent: permeability and vascularization. Generally, tissue permeability 
and angiogenesis are closely related, because neo-vascularization usually occurs under (re-) 
organization of endothelial cell architecture, e.g. by replacing cellular material. It had been a 
matter of debate, if these two actions are interdependent as one highly coordinated, sequential 
operation [137], which now has been resolved. In the healthy body, neo-vascularization as a 
permanent process is the result of pro- and anti-angiogenic factors and essential for the 
organism to repair damages like wounds, regulating the female reproduction cycle [138] or 
promoting embryogenesis, for instance [139]. To induce blood vessel growth, VEGF 
stimulates RTK`s expressed on the cell surface of endothelial cells as their primary target 
(there exist few other non-endothelial cell types, which also respond to VEGF such as retinal 
pigment epithelial cells [140], pancreatic duct cells [141] and Schwann cells [142]). 
Subsequently, a rapid increase of intracellular [Ca2+] can be observed within seconds after 
exposure [143] as a first reaction. While in vitro studies demonstrated VEGF promoting 
endothelial cells to invade collagen gels and forming capillary-like structures [144, 145], in 
vivo models confirmed remarkable pro-angiogenic effects [146, 147] just like sprouting, 
proliferation, migration and tube formation in endothelial cells. Increased tissue permeability 
is an important component of the very early inflammatory response [148] allowing fluid to 
leave and enter the surrounding tissue. At this stage, VEGF is typically induced by the 
hypoxia inducible factor (HIF) regulated elements of the VEGF gene under hypoxic 
conditions. Moreover, it is considered the principal cytokine to induce a transient, reversible 
microvascular leakage by fenestrating capillaries [143, 149]. In addition, VEGF has been 
shown to cause vasodilatation in vitro [150], tachycardia, hypotension and a decrease in 
cardiac output in conscious rats [151]. Taking these facts into account, it is not surprising that 
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VEGF can play pivotal roles in certain pathologies related to cell proliferation and 
locomotion, including tumors, psoriasis, ischemic heart disease, diabetic neuropathies, age-
related macular degeneration [152] and others. For some years, targeted anti-tumor therapies 
in form of anti-VEGF antibodies have gained attention in oncology. The first chemotherapy 
was established in 2004 by bevacizumab in the treatment of colon cancer. Soon thereafter, 
several multi-targeted kinase inhibitors (MTKI`s) followed. In the light of VEGF-related 
hypotension, one main side effect among this group of therapeutics is hypertension, which is 
observed in up to 80% of the patients and sometimes can limit the therapy [136]. 
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2.5. Mammalian Wound Healing 
Substances out of Phyllostachys edulis and Rosa damascena were tested employing a 
computer-assisted modification of the classical scratch assay. Therefore, epithelial cells under 
influence of these compounds were observed tracing cell locomotion by time lapse pictures. 
Thus, it is important to briefly specify major stages and processes during wound healing.  
The skin poses the body`s outer sheath and can be regarded as the first line defense to protect 
the organism from the environment – a condition which is indispensable to life. Thus, every 
animal in existence has evolved repair mechanisms as a reaction to injuries [153]. As 
mentioned in the chapter “Inflammation”, a mechanical damage, that is a cutaneous or 
subcutaneous wound, is one trigger to activate the inflammatory response, but inflammation is 
only a part of the entire wound healing process, which remains to be fully elucidated. In this 
regard, Reinke and Sorg [154] distinguish between the “regeneration” and the “reparation” of 
wounds. The first is characterized by a substitution of the tissue (e.g. of superficial 
epidermis), the latter is the predominant form in adults and happens in an unspecific fashion 
in which the healing process finally results in fibrosis for instance. However, depending on 
the acuteness (size, depth, cleanliness etc.) of the insult, a set of pathways can be activated 
governing blood coagulation, cell locomotion-governed processes of epithelial cells, blood 
vessel restoration, and of course certain immune system-related cascades. If the survival of 
the organism is secured, the distinct and immediate onset of all these actions must gradually 
fade, which is part of the recovery [2]. Typically, the physiological endpoint of reparation is a 
patch of cells (primarily fibroblasts) and extracellular matrix in abundance, commonly known 
as a scar. It restores the continuity of tissue, but does not behave like the surrounding tissue in 
regards of cohesion and performance. Once functional tissue never regains the former 
material stability; Singer and Clark report a 70%-breaking strength compared to normal skin 
[155]. Interestingly, some eukaryotic organisms are capable to fully regain tissue function 
after injury, for example humans during prenatal development [156]. The question of why this 
ability is lost with maturation to adulthood remains [157]. Unique to humans, there exist 
abnormal progressions, when wound healing drifts into a pathologic state, such as over-
healing specified by the growth of keloids and hypertrophic scars, or under-healing 
manifested in chronic wounds with a retarded or defective closure mechanism. Taken 
together, these are the major biomedical challenges in wound healing [158]. In brief, the full 
course of reparation of injuries can be divided into three distinct, but overlapping stages: 1. 
homeostasis; 2. re-epithelialization; 3. remodeling. 
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Homeostasis and Inflammation Phase (I) 
In the strict sense, the first stage of wound healing consists of two interdependent reactions: 
the vascular (homeostasis) and the cellular response (inflammation). Right after flushing the 
injury with blood and lymph fluid to remove microorganisms, antigens or cell debris [159], 
the organism`s priority is to establish a provisional wound matrix within only a few hours. 
Simultaneously with the activation of the extrinsic and intrinsic coagulation cascades, a 
transient vasoconstriction prevents further blood loss and supports a first wound closure by a 
blood clot. This “plug” serves as a reservoir for cytokines and growth factors and consists of 
structure-providing proteins like cross-linked fibrin, fibronectin, thrombospondins and other 
molecules, which are essential 
for enabling the migration of 
leukocytes, keratinocytes, 
fibroblasts and endothelial cells 
[154] (Fig. 9). Subsequently, the 
temporary vasoconstriction is 
followed by a sustained 
vasodilation (“rubor”) to 
facilitate thrombocytes invade 
the matrix [160], which 
themselves release chemokines 
to attract white blood cells. 
Leukocytes in turn release cytokines including TNF-α, IL-1β, IL-6, IL-8, VEGF and other 
mediators to activate the inflammatory response, while the affected tissue typically shows an 
edematous, hypoxic picture.  
The inflammation phase basically continues in a fashion described in chapter 2.4 
“Inflammation” including the attraction of sensor cells and subsequent activation of immune 
reactions. Accounting for the time line, the total period of homeostasis/inflammation is 
strongly depending on the dimension of the wound and if it is encumbered by a bacterial 
infection. However, neutrophils responsible for bacterial degradation and attraction of other 
leukocytes arrive about 24h after injury and are present for circa two to five days (Fig. 9). 
According to Eming et al. [160], the activity of neutrophils ceases after a few days, while 
macrophages reach the site of injury within approximately two days after wounding. Not only 
responsible for host defense and phagocytosis of pathogens and cell debris [161], 
Fig. 9: Inflammation phase (I) - building of a blood clot. Figure 
adopted from Gurtner et al. [2]. 
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macrophages also release their own pattern of cytokines/chemokines, which are essential for 
the continuance of the physiologic course of wound healing comprising the transition to the 
next stage: re-epithelialization [2]. 
 
Re-epithelialization and Granulation Phase (II) 
 While a successful first stage of wound healing is crucial for survival, the second stage 
concentrates on resurfacing of the wounded area, formation of granulation tissue and re-
establishment of mechanical strength. Therefore, proliferation of fibroblasts is upregulated to 
provide enough cells to immigrate from the edges of the wound along the fibrin matrix. 
Moreover, angiogenetic 
processes ensure a restoration of 
the vascular network [162, 163] 
(Fig. 10). Substances like 
collagen and fibronectin (ECM) 
fill out spaces and gaps and pose 
as the backbone for new 
connective tissue. As soon as the 
tissue loss is compensated, the 
re-epithelialization sets in by 
migration and maturation of 
keratinocytes to build up a 
surface layer above the granulation tissue on the one hand and on the other by epithelial stem 
cells derived from hair follicles or sweat glands [164-166]. Also, this process is boosted by 
numerous cytokines and growth factors, such as epidermal growth factor (EGF), keratinocyte 
growth factor (KGF), insulin-like growth factor-1 (IGF-1) and nerve growth factor (NGF) 
[167]. Movement of cells is a complex, tightly regulated process, which involves cytoskeletal 
interaction with RhoGTPases including Rho, Rac and Cdc42 [168, 169]. These RhoGTPases 
primarily regulate the intracellular organization of fibers and thereby enable cell locomotion. 
Resurfacing is completed, when the epithelial cells on the leading edge of the wound touch 
each other, restoring the barrier function of the skin. Besides cell motility, newly formed 
tissue needs nutrients to survive. Initiated by several growth factors, neovascularization and 
angiogenesis ensure a proper blood supply. In brief, VEGF for instance binds to endothelial 
receptors of existing vessels and thereby activates certain signaling cascades accordingly. 
Subsequent endothelial secretion of proteolytic enzymes, which dissolve the basal lamina, 
Fig. 10: Re-epithelialization phase (II) - re-surfacing the wound and 
establishing a vascular network. Picture adopted from Gurtner et al. 
[2]. 
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leads to proliferation and migration into the wound, forming a new tubular network of vessels. 
This action has been described as “sprouting” [154]. Angiogenesis is then completed by the 
re-establishment of blood perfusion. Finally, the formation of a transient granulation tissue 
replaces the provisional wound matrix and consists of dense fibroblasts, granulocytes, 
macrophages, capillaries and loosely organized collagen bundles. Granulation tissue is highly 
vascular, for which reason it appears with a classic redness and is characterized by a certain 
vulnerability. This point displays the transition to the third stage of wound healing, because 
remodeling already starts with forming and degrading of ECM [170, 171], as well as 
maturation of fibroblasts to myofibroblasts and consecutive apoptosis [172]. This second 
phase of wound healing is reported to last about 2-10 days [2]. 
 
Tissue Remodeling Phase (III) 
The last phase of wound healing is mostly characterized by the change of collagen structure. 
During the previous proliferation phase, fibroblasts produced mostly disorganized collagen 
type III as a component of the granulation tissue. Collagen type III is now successively 
replaced by the stronger collagen 
type I, which is organized in 
small parallel bundles [173] 
(Fig. 11). The ratio of collagen 
type I and III is reported to be 
critical for proper wound healing 
and can be a determinant for 
scarring [174]. Additionally, 
angiogenesis and blood flow 
slowly declines in the newly 
formed tissue causing a termination 
in metabolic activity [154]. Myofibroblasts provoke a contractile response and thereby, 
decrease the surface of the scar [175]. Finally, most of the endothelial cells, macrophages and 
myofibroblasts undergo apoptosis or exit the wound. Epithelial-mesenchymal cross-talk 
regulates skin integrity and homeostasis [176]. After serious injury, subepidermal appendages 
including hair follicles or sweat glands neither heal, nor grow back. The last phase in wound 
healing can take up to 12 months, in some cases even longer [2]. 
Fig. 11: Tissue remodeling phase (III) - the purple area 
represents disorganized collagen type III laid down by 
fibroblasts. Picture adopted from Gurtner et al. [2]. 
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3. Results and Discussion 
3.1. In Vitro Anti-Inflammatory and Wound-Healing Potential of a Phyllostachys edulis 
Leaf Extract – Identification of Isoorientin as an Active Compound 
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Abstract 
Extracts prepared from the leaves of Phyllostachys edulis (bamboo) have received attention in 
pharmacological research due to their potent antitumor, anti-inflammatory, antimicrobial, and 
antiulcerogenic activities. In this study, anti-inflammatory effects of a bamboo leaf extract 
(BLE) on TNFα -induced overproduction of IL-8, VEGF and IL-6 in immortalized human 
keratinocytes (HaCaT) were investigated for the first time. In addition, wound healing effects 
were evaluated in 3T3-swiss albino mouse fibroblasts. BLE and isoorientin inhibited the TNF-
α induced release of IL-8 and VEGF. Furthermore, isoorientin dose dependently reduced levels 
of IL-6 in TNF-α treated HaCaT cells. Wound-healing was evaluated using a modification of 
the classical scratch assay. For evaluation of the wound gap, a new computerized method based 
on time-lapse microscopy was developed. It was shown that BLE (10 μg/mL) improved wound 
closure by 28 % (12 h) and 54% (24 h), respectively. In concentrations of 50 μg/mL and above 
BLE inhibited cell migration without affecting cell viability. Isoorientin (10 μM) improved 
wound closure by 29 % (12 h) and 56 % (24 h). Comparable to BLE, higher concentrations of 
isoorientin prevented cell migration. It is suggested, that BLE as well as isoorientin exert a dual 
activity – in higher doses anti-inflammatory effects, and in lower concentrations antiangiogenic 
activities.  
 
 
 
 
 
 
Keywords: Phyllostachys edulis, Poaceae, bamboo, wound healing, anti-inflammatory, time-
lapse microscopy 
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Introduction 
Wounds are defined as physical injuries that result in an opening or break of the skin that causes 
disturbance in the normal skin anatomy and function [1]. Wound healing can be grouped 
roughly in three different phases: the initial inflammation is followed by the granulation phase 
connected to re-epithelialization and in the end the long-term process of remodeling [2]. The 
inflammations' onset happens immediately after injury. It his highly regulated and depends 
upon pro-inflammatory mechanisms, which are gradually counteracted by various anti-
inflammatory pathways mediated by factors like IL-10, hormones, and neurotransmitters [2]. If 
the anti-inflammatory response prevails, the process turns into the next stage of granulation and 
fibroblasts and keratinocytes migrate into the wound. Angiogenesis mediates capillaries to 
replace the fibrin matrix with granulation tissue, which depicts a substrate for keratinocyte 
migration at later stages. Maturation of the keratinocytes leads to a restoration of the 
epithelium's barrier function [3]. Contraction of the wound is done by fibroblasts located at the 
wound's edge that differentiated into myofibroblasts producing extracellular matrix (ECM) [3]. 
The final stage is specified by remodeling of the tissue's architecture [3]. 
In terms of wound healing, IL-6, IL-8 and VEGF are key players in these processes. IL-6 has 
both pro- and anti-inflammatory properties. TNF-α depicts a physiologic stimulus to IL-6 [4]. 
As a member of the chemokine family, IL-8 possesses chemotactic properties attracting 
neutrophils. Furthermore, it induces neutrophils to release lysosomal enzymes [5] and down-
regulates collagen expression by fibroblasts [6]. Just like IL-6, its production is stimulated by 
the presence of TNF-α. Vascular endothelial growth factor (VEGF) is known to play a pivotal 
role in angiogenesis, but is also involved in acute inflammatory processes. It can be considered 
a mitogen, which regulates endothelial paracellular permeability and proliferation of 
mesenchymal cells. At the location of the wound and in endothelial cells of granulation tissue, 
VEGF and its receptor production are typically up-regulated [7].  
Cells in unhealed wounds constantly produce inflammatory mediators in an uncoordinated and 
self-sustaining phase of inflammation that impairs the restoration of anatomic and functional 
integrity in the normal period of time [8, 9]. Thus, a prolonged inflammatory phase leads to 
delayed wound healing. Several wound healing strategies are therefore under development 
which target the major phases of cutaneous wound healing: inflammation, proliferation, and 
tissue remodeling. In this regard, medicinal plants have always been in the focus of several 
research programs to identify compounds with potential anti-inflammatory and wound healing 
properties [10]. 
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Phyllostachys edulis (Carrière) J. Houz. (Poaceae) is one of the most important Chinese bamboo 
species economically [11]. While bamboo stems are widely used in furniture production the 
leaves are a byproduct during harvesting. Thus, research projects focusing on the valorization 
of bamboo leaf products towards utilization in the nutrition or cosmetic industry have gained 
considerable attention. It was shown that bamboo leaf extract exerts potent antitumor, anti-
inflammatory, antimicrobial, and anti-ulcerogenic activities [12-16]. Recently, a special 
bamboo gauze coated with polymer and drug was developed as surgical bandage to facilitate 
faster wound healing [17]. It was the aim of the present study to investigate the anti-
inflammatory and wound-healing potential of a Phyllostachys edulis leaf extracts in in vitro 
models in comparison to the flavonoid isoorientin which was identified as one of the major 
compounds.  
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Results 
In order to determine potential cytotoxic effect of BLE (10-250 μg/mL), isoorientin (5 – 100 
μM) and hydrocortisone (5-100 μM) in HaCaT cells, the MTT assay was used. Treatment with 
the different test compounds for 24 h at indicated concentrations had no significant cytotoxic 
effects on HaCaT cells. The cell viability for hydrocortisone ranged between 100 – 113%, for 
BLE between 100 – 103% and for isoorientin between 93 - 100% (Fig. 1S). Thus, extract 
concentration ranged from 25 – 250 μg/mL for subsequent experiments. Isoorientin (Fig. 1) 
was used in further experiments in concentrations ranging from 10-100 μM. Interestingly, 
hydrocortisone slightly increased cell viability in the used concentrations. However, no dose 
dependent effect was observed. For subsequent experiments, hydrocortisone was used in a 
concentration of 10 μM (or 3.6 μg/mL, correspondingly). 
 
Figure 1: LC-MS chromatogram of a P. edulis leaf extract representing the total ion chromatogram (TIC) with 
only flavonoids annotated. (Color figure available only.) 
 
To investigate whether BLE or isoorientin inhibit TNF-α-induced IL-6, IL-8 and VEGF 
expression, HaCaT cells were treated with TNF-α (20 ng/mL) after pre-incubation of cells for 
6h with the various treatments. The results were compared to those of hydrocortisone (10 μM 
or 3.6 μg/mL, correspondingly). BLE had no effect on the TNF-α induced production of IL-6 
(Fig. 2A). In contrast, isoorientin dose-dependently decreased IL-6 production in 
concentrations of 50 μM and 100 μM (Fig. 2B). As presented in Fig. 2C, upregulation of IL-8 
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by TNF-α treatment was dose-dependently reduced by BLE and isoorientin treatment (Fig. 2D). 
The effects on TNF-α induced production of VEGF are shown in Fig. 2E, F. BLE significantly 
decreased TNF-α stimulated VEGF production in HaCaT cells; isoorientin dose-dependently 
decreased TNF-α induced VEGF levels (Fig. 2F). 
Figure 2: Effects of BLE, isoorientin and hydrocortisone on TNF-α (20 ng/mL) induced IL-6, IL-8 and VEGF 
secretion in HaCaT cells. IL-6, IL-8 and VEGF secretion were quantified by corresponding ELISA kits. Results 
are expressed as Mean ± SD of four independent experiments. *p<0.05, **p<0.01, ***p<0.001 vs. TNF-α 
stimulated group; +++p<0.001 vs. untreated control group. 
 
Effects of BLE and isoorientin on the migration of 3T3 mouse fibroblasts were tested in an in 
vitro wound healing model, in which wounds were generated using silicon culture inserts. Cells 
were allowed to migrate across the rectangular region of interest ROI into the center of the 
wound gap (width 450 µm) for 24 h at 37 °C. A clear difference was observed between cells 
treated with DMEM (0% FCS) or with DMEM + 2% FCS (positive control) (Fig. 3A-D). 
Addition of 2% FCS to the medium significantly increased cell migration over a period of 24 h 
resulting in a 65% closed wound gap. In contrast, in cells treated with DMEM without any FCS 
supplementation the wound closure was approximately 20% after an observation period of 24h. 
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Figure 3: Effects of bamboo leaf extract and isoorientin on cell migration in 3T3 mouse fibroblasts. Graphs show 
the percentage of the predefined rectangle covered by cells over an observation period of 24 h (A, B) and the 
corresponding area under the curve (AUC) in μm2 x t (C, D). Data represent the Mean ± SD of two independent 
experiments. *p<0.05, **p<0.01, ***p<0.001 vs. 0% FCS control group; ##p<0.01 vs. 50 μg/mL BLE. 
 
BLE in a concentration of 10 μg/mL significantly increased the cell migration rate if compared 
to the 0% FCS group (Fig. 3 A,C). A wound gap closure of approximately 55% was observed 
after 24 h. In concentrations of 50 μg/mL and 100 μg/mL of BLE, no statistically significant 
effects versus the 0% FCS control group were observed. However, multiple post-hoc 
comparisons between groups revealed a significant difference between the 50 μg/mL and 100 
μg/mL BLE group (p< 0.01), indicating a stronger cell migration inhibitory effect in higher 
concentrations. 
Isoorientin treated cells started to migrate into the region of interest at 6 h after removal of the 
silicon insert (Fig. 3B). Interestingly, the 24 h migration rate was slightly higher in a 
concentration of 10 μM than in higher concentrations and after 24 h approximately 55% of the 
wound gap were closed (Fig. 3B). In addition, treatment with 25, 50 and 100 μM of isoorientin 
could increase the overall migration rate within 24h although no difference between the various 
concentrations could be observed (Fig. 3D).  
Since AUC and migration rate measurements showed only small statistical differences between 
the treatment groups, further image analyses were performed. It was of special interest to 
compare the effects of BLE and isoorientin in lower concentrations (Fig. 4). Using long term 
time-lapse imaging interval snap-shots of predefined positions in the gap during 0 h, 6 h, 12 h 
and 24h were taken (Fig. 4). Detailed image analysis showed that after 24 h BLE (10 μg/mL) 
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and isoorientin (10 μM) significantly increased cell migration into the region of interest if 
compared to the 0% FCS negative control group. If compared to the 2% FCS positive control 
group, BLE and isoorientin achieved a wound gap closure of 55% after 24h. 
Figure 4: Cell migration in response to an artificial injury using long term time-lapse imaging interval snap-shots 
of predefined positions in the wound gap (450 μm) during 0 h, 6 h, 12 h and 24h (Fig. 4). Cells were treated with 
the negative control 0% FCS, the positive control 2% FCS as well as BLE (10 μg/mL), or ISO (isoorientin; 10 
μM).  
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Discussion 
Pro-inflammatory cytokines such as TNF-α and IL-6 are increased in the inflammatory phase 
of wound healing [2]. While TNF-α at low concentrations promotes wound healing by 
stimulation of inflammation, it has a destructive effect on wound repair in higher concentrations 
[2]. Interleukin-6 is produced in epidermal cells, fibroblasts and dermal endothelial cells under 
normal conditions but it is also synthesized by inflammatory cells infiltrating the skin in 
different pathological conditions [18]. Therefore, inhibition of pro-inflammatory mediators 
secreted from activated keratinocytes may be an effective therapeutic approach to regulate the 
progression of the wound healing process.  
In the present study, the spontaneously immortalized human keratinocyte cell line HaCaT was 
used for the evaluation of anti-inflammatory activities. HaCaT cells maintain normal 
keratinocyte morphology and full epidermal differentiation capacity and remain non-
tumorigenic [19]. Like human primary keratinocytes they produce cytokines and chemokines 
[20] which are involved in the development of inflammatory skin diseases. 
Several plant extracts and natural compounds have been reported previously to have anti-
inflammatory effects in activated keratinocytes [21-24]. In the present study, we found that 
BLE could not prevent the TNF-α mediated inflammatory response to IL-6 in HaCaT cells. It 
was demonstrated in a previous study that a hydroalcoholic extract prepared from the fresh 
leaves and branches of Phyllostachys edulis significantly reduced IL-6 overproduction under 
lipotoxic conditions in murine C2C12, 3T3-L1, and Hepa6 cells [15], most likely through an 
activation of NF-κB and AP-1 pathways. The different results of the two studies could be 
explained by either a different extract (fresh versus dry leaves) and/or different cell models. 
When cells were pretreated with isoorientin (50 µM and 100 µM), the secretion of IL-6 was 
significantly reduced, comparable to that of the positive control hydrocortisone. IL-6-inhibition 
by isoorientin was not due to a general cytotoxic effect, since cell viability in all cultures 
remained constant throughout the incubation period in the presence of all compounds tested. 
Anti-inflammatory activities of isoorientin have been reported in previous studies. For example, 
Conforti et al. [25] reported that isoorientin exerts significant anti-inflammatory activity 
through inhibition of NO production in LPS stimulated mouse macrophage RAW264.7 cells, 
and Kupeli et al. [26] demonstrated an inhibition of carrageenan-induced hind paw edema 
model in mice. Further, our data on isoorientin are in good correlation with the data of Yuan et 
al. [27] who demonstrated that isoorientin significantly increased cell viability in mouse 
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microglial (BV-2) cells, blocked the protein expression of inducible nitric oxide synthase and 
cyclooxygenase-2, and decreased the production of nitric oxide, pro-inflammatory cytokines 
including TNF-α and interleukin-1β. 
Vascular endothelial growth factor (VEGF) and the chemokine IL-8 play an important role in 
skin inflammation and are produced by activated keratinocytes [28, 29]. It has been 
demonstrated that TNF-α activates epidermal cells and induces the production of VEGF and 
IL-8 [30, 31]. Both mediators are overexpressed in skin diseases which are associated with 
aberrant angiogenesis [32-34]. In the present study, BLE could reduce VEGF and IL-8 levels 
induced by TNF-α in HaCaT cells. Isoorientin, which was identified as the main flavonoid in 
BLE, significantly reduced TNF-α induced increase in VEGF and IL-8 production. To our 
knowledge, no data were previously published on the effects of Phyllostachys edulis extracts 
and isoorientin on the secretion of VEGF and IL-8. Isoorientin is one of the major active 
compounds in Phyllostachys edulis which contributes to the moderate anti-inflammatory effects 
of the leaf extract by suppressing TNF-α induced production of proinflammatory cytokines (IL-
6), chemokines (IL-8) and VEGF in HaCaT keratinocytes. Thus, isoorientin might have a 
potential as therapeutic agent for inflammatory skin diseases. However, it needs to be 
investigated in further studies in how far other polyphenols contribute to the overall activity of 
this plant and in how far interactions among fractions and compounds is important for the 
activity. Interestingly, extracts derived from either Phyllostachys edulis or other bamboo 
species have shown potential anti-inflammatory activities [12, 15, 35].  
As mentioned previously, cutaneous tissue repair involves a complex reaction [36]. Fibroblasts 
play a critical role in normal wound healing. They are involved in key processes such as forming 
granulation tissue by proliferating and migrating and for creating new collagen structures to 
support the other cells associated with effective wound healing, as well as contracting the 
wound [37, 38]. Thus, it was of interest to investigate the effects of BLE as well as of isoorientin 
on this cell type to reveal if these compounds can contribute to the wound healing process. We 
performed a modification of the classical scratch assay by using cell seeding stoppers which 
were applied to the plate bottom. After the cells reached confluence the inserts were removed 
causing a gap of 450 μm. The cells then migrate across the created gap. Long term time-lapse 
imaging was performed by taking interval snap-shots of predefined positions in the gap during 
24 h, thus minimizing error when compared with other methods that measure wound closure. 
This is an accurate and reproducible model to study wound healing by monitoring cell migration 
over an extended period. 
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Wound closure was improved by 28 % (12 h) and 54% (24 h), respectively, in the presence of 
10 μg/mL BLE. Interestingly, higher concentration of the BLE inhibited cell migration without 
affecting cell viability. Isoorientin at a concentration of 10 μM improved wound closure by 29 
% (12 h) and 56 % (24 h), respectively. Similar to BLE, higher concentrations of isoorientin 
prevented cell migration into the area of interest without considerable toxic effects. Based on 
these findings we hypothesize that the inhibition of cell migration of fibroblasts in a collagen 
matrix could be a result, in part, of the reduction of VEGF secretion. Our data show that TNF-
α induced VEGF secretion was decreased at higher doses of BLE and isoorientin. We therefore 
suggest that BLE as well as isoorientin might have a dual activity – in higher doses (> 100 
μg/mL extract or > 25 μM isoorientin) the compounds show an anti-inflammatory effect while 
in lower concentrations (≤ 10 μg/mL extract or ≤ 10 μM isoorientin) both compounds exert 
antiangiogenic activities by inhibiting migration possibly by prevention of VEGF secretion.  
In conclusion, natural accelerators of cutaneous tissue repair with simultaneous anti-
inflammatory activities are of great interest for a variety of dermatological disorders. Thus, 
treatment with Phyllostachys edulis leaf extract or isoorientin may be a potential therapeutic 
strategy to promote wound healing and to prevent inflammation in a persistent inflammatory 
condition. Further investigations of the precise mechanism by which Phyllostachys edulis and 
isoorientin reveal anti-inflammatory as well as wound healing properties are currently 
underway.  
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Materials and Methods 
Materials 
4′,6-Diamidino-2-phenylindole dihydrochloride, Dimethyl sulfoxide (DMSO), Acetic Acid 
99,7 %, Sodium dodecyl sulfate (SDS), isoorientin (purity > 98 %), hydrocortisone (purity > 
98 %), and 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide ("MTT" 
purity 98%) were purchased from Sigma-Aldrich. IL-6, IL-8 and VEGF human ELISA kits 
were purchased from LubioScience. Ibidi Culture-Inserts for Live Cell Analysis were obtained 
from Vitaris AG. Dulbecco's Phosphate buffered saline [-] CaCl2; [-] MgCl2 was purchased at 
Lubio science Invitrogen. Recombinant human TNF-alpha (purity > 97 %) was purchased at 
R&D Systems. Collagen Type I Rat Tail solution (purity > 90 %) was purchased at BD 
Biosciences. 
 
Cell culture 
Human HaCaT cells from histologically normal skin and Swiss 3T3 albino mouse fibroblasts 
(both from Cell Line Services) were maintained in Dulbecco's Modified Eagle's Medium 
supplemented with 1% Penicillin 10.000 U/mL / Streptomycin 10.000 µg/mL, and 10% fetal 
calf serum (FCS) (all from LubioScience) at 37 °C in a humidified atmosphere containing 5% 
CO2 [19]. 
 
Plant material and extract preparation 
The plant material of P. edulis was provided by Organic Bamboo Industries. It was identified 
by Mr. Liao Rong Qi, forest chief of Yangzhuang Town Station, WuYiShan, Fujian, China. 
Dried bamboo leaves (0.5 g) were grinded and extracted by Soxhlet extraction with water (30 
mL) and finally lyophilized (final yield 100 mg). Voucher specimen of the corresponding 
extract (ICB_BLE2013_10) are deposited at the Institute for Chemistry and Bioanalytics, 
School of Life Sciences, University of Applied Sciences Northwestern Switzerland. The 
purified extract was separated on a Zorbax SB Phenyl column (3.0 x 150 mm, 1.8 µm) in 
gradient mode (25-95 B %, A water, B methanol plus 0.1 formic acid) with a flow rate of 0.4 
mL/min at 35°C. Injection volume was set to 1 µL.  Analysis was performed on an Agilent 
6410 Triple Quadrupol Mass spectrometer with an electros spray ionization source operated in 
positive mode with an Agilent 1200SL HPLC System running under MassHunter B05.02. The 
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amounts of major flavonoids were quantified using a LC-MS/MS method. The quantification 
of individual flavonoids was performed by separate LC-MS/MS (SRM) experiments (data not 
shown). Isoorientin (Fig. 1) was detected as one of the main flavonoids with amounts of 5.32 
g/kg. A flavonoid profile of a bamboo leaf aqueous extract is shown in Fig. 1.  
 
Cell viability assay 
To assess cell viability, the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid-test 
(MTT-test) was conducted. Therefore, 200 µL of the HaCaT cell suspension was seeded into 
96-well plates at a concentration of 6x104 cells/well followed by an incubation period of 24 h 
(37 °C, 5% CO2). After the incubation time the medium was discarded and the cells were 
washed with 150 µL PBS. The samples solved in DMEM were added in a dilution series. All 
sample solutions were dissolved in serum-free medium. The extract was tested in 
concentrations of 10, 25, 50, 100 and 250 μg/mL, hydrocortisone (positive control) and 
isoorientin were tested in concentrations of 5, 10, 25, 50 and 100 μM. Four independent 
experiments with triplicates were conducted. The controls consisted of wells with or without 
cells with pure DMEM or the solvent standard DMSO. After an incubation period of 24 h, 10 
µL of MTT-solution (5 mg/mL PBS) was added and again incubated for 2h. The liquid was 
discarded before adding 100 µL of the cell-lysis buffer consisting of 99.4% DMSO, 0.6% 
Acetic Acid and SDS 0.1 g/mL. The optical density was read at 570 and 630 nm as a reference 
on a microplate reader (SpectraMax M2e). The viability was calculated according to the 
formula: 
 
𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 [%] =
𝑂𝐷 570 𝑛𝑚 (𝑠𝑎𝑚𝑝𝑙𝑒) − 𝑂𝐷 630 𝑛𝑚 (𝑠𝑎𝑚𝑝𝑙𝑒)
𝑚𝑒𝑎𝑛 𝑂𝐷 570 𝑛𝑚 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙) − 𝑚𝑒𝑎𝑛 𝑂𝐷 630 𝑛𝑚 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
 
 
The experiments were executed utilizing cell culture passage numbers from 35 to 70. 
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Antiinflammatory activity 
The experimental setup as well as the concentration of TNF-α for these experiments were 
chosen according to Park et al. [23] with some modifications. Briefly, HaCaT cells (7x105 cells 
per well, 12-well plates) were pre-incubated in a culture incubator for 6 h without or with the 
addition of different concentrations of BLE (25 – 250 μg/mL), isoorientin (10 – 100 μM) or 
with the positive control hydrocortisone (10 μM) before adding the pro-inflammatory cytokine 
TNF-α. After a pre-incubation time of 6h, TNFα (20 ng/mL) was added and the cells were 
incubated for further for 24 h. After the total incubation time of 30 h, VEGF, IL-8 and IL-6 
were measured in cell supernatants by enzyme-linked immunosorbent assays kits as biomarkers 
of anti-inflammatory response according to manufacturer’s instructions. Absorbance was 
measured at 450 nm using a microplate reader (SpectraMax M2e). 
 
Cell migration assay (Wound healing scratch assay) 
After positioning the cell culture inserts in the 12-well dishes, the 3T3 mouse fibroblasts were 
inoculated in a concentration of 4x105 cells/mL into the collagen-coated wells. After an 
incubation time of 24 h, the cells reached confluence and the inserts were removed causing a 
gap of 450 μm. The subsequent washing with 1 mL PBS was followed by the manual addition 
of a scratch on the side of the well by a 100 µL pipette tip. In different concentrations 
accordingly, the wells we charged with the test compounds. BLE and isoorientin were dissolved 
in DMEM containing 0.2 % FCS. DMEM supplemented with 2% FCS was used as positive 
control, 0% FCS (DMEM without supplements) was used as negative control. Long term time-
lapse imaging was performed using the Olympus IX83 automated inverted microscope platform 
for live cell imaging (Olympus). Interval snap-shots of predefined positions in the gap during 
24 h were taken. Exact positions were defined in each gap of every well by using the Olympus 
software package cellSens Dimension 1.81 and the cells were observed for 24 h. BLE was in 
the concentrations 10, 50 and 100 µg/mL and isoorientin in concentrations of 10, 25, 50 and 
100 µM. All experiments were conducted using passage numbers from 43 to 50. 
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Statistics 
Data are shown as mean ± SD. All experiments were performed in triplicate and each 
experiment was repeated four times. Statistical analysis of data was carried out by one-way 
analysis of variance (ANOVA) followed by Dunnett's and Tukey’s multiple comparison test 
using the software package GraphPad Prism (version 5.01, GraphPad Software Inc.). In all 
cases differences were considered significant if p < 0.05.  
The following computerized approach was used for evaluating cell migration: After selecting a 
rectangle (region of interest "ROI") in the cell-free gap by appropriate software tools, the area 
was calculated in [µm2] automatically and set as 0 % µm2 covered surface (defined as ‘Area of 
region of interest, AoRoI’). Due to the migration of the cells into the ROI, the value for AoROI 
of the covered surface increased over time. The principle of measurement was based on a 
modified pixel counting by the software package. At t = 6, 12, 18 and 24 hours, the AoROI was 
measured and its value plotted in graphs. The area under the curve AUC24h was computed by 
GraphPad Prism and depicts the magnitude of wound closure in one value.  
 
 
 
 
Supporting information 
Fig. 1S, showing the cell viability data, can be found as Supporting Information 
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Figure 1S: Effect of BLE, isoorientin and hydrocortisone on cell viability in HaCaT cells. After pre-treatment of 
24 h with the test compounds cell viability was measured using the MTT assay. Data are expressed as percentage 
and values represent the Mean ± SD of four independent experiments. *p<0.05, **p<0.01, ***p<0.001 vs. 
untreated control group.  
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3.2. Polyphenol-Enriched Fraction of Rose Oil Distillation Wastewater Inhibits Cell 
Proliferation, Migration and TNF-α-Induced VEGF Secretion in Human Immortalized 
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Abstract 
Water steam distillation of rose flowers separates the essential oil from the polyphenol 
containing rose oil distillation waste water (RODW). Recently, a strategy was developed to 
separate RODW into a polyphenol depleted water fraction and a polyphenol enriched fraction 
[RF20-(SP-207)]. Polyphenols are known to have a wide spectrum of biochemical and 
pharmacological effects. In particular, rose petals are known to contain compounds with 
potential anti-proliferative activity, such as flavonoids, gallic and protocatechuic acids, and 
tannins. 
The objective of the present study was to investigate RF20-(SP-207) and a fraction F(IV) 
augmented in quercetin and ellagic acid for possible anti-proliferative effects in immortalized 
human keratinocytes (HaCaT).  
The data demonstrated that RF20-(SP-207) revealed a dose dependent anti-proliferative activity 
(IC50 of 9.78 µg/mL). In a non-toxic concentration of 10 µg/mL, this effect was stronger than 
that of the two positive controls LY294002 (10 µM, PI3K-inhibitor, 30 % inhibition) and NVP-
BEZ235 (100 nM, dual PI3K/mTOR-inhibitor, 30 % inhibition) and clearly exceeded the anti-
proliferative action of quercetin (50 µM, approx. 25 % inhibition) and ellagic acid (1 µM, 
approx. 15% inhibition). Time lapse microscopy detected a significant impairment of cell 
migration under influence of RF20-(SP-207) and F(IV). At concentrations of 10 µg/mL of both, 
extract and fraction, cell migration was strongly suppressed (51% and 28% gap closure, 
respectively, compared to 95% gap closure 24 hours after control treatment). The suppression 
of cell migration was comparable to the positive controls LY294002 and NVP-BEZ235 and to 
quercetin. Furthermore, basal and TNF-α stimulated VEGF-secretion was significantly reduced 
by RF20-(SP-207) and F(IV) at 10 µg/mL (approx. 50 % compared to the untreated control).  
In conclusion, RF20-(SP-207) has been shown to be very promising in terms of controlling cell 
proliferation and migration and could be developed as a supportive, local therapy against hyper-
proliferation-involved skin diseases such as plaque psoriasis.  
 
 
 
Keywords: Rosa damascena, Rosaceae, waste water, quercetin, ellagic acid, cell 
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Introduction 
Rosa damascena Mill. f. trigintipetala Dieck (Rosaceae), commonly known as the oil bearing 
rose, is a plant rich in polyphenolic constituents with numerous biological activities such as 
anti-HIV, anti-bacterial, anti-oxidant, anti-tussive, anti-diabetic, anti-inflammatory and anti-
plasmodial [1]. The flowers are annually harvested in the rose valley of Bulgaria in large 
quantities to extract its essential oil for the food and cosmetic industry. Rose oil production 
therefore poses a respectable economic factor. However, during steam distillation of the rose 
flowers the distillation water containing large amounts of polyphenolic compounds remains as 
the major part of the waste. During a single industrial distillation cycle approx. 4000 L of liquid 
waste are generated [2], thus causing a principal environmental problem in the area of the 
production. Currently, there is no common practice for rose oil distillation waste management. 
Following the completion of the distillation, the hot residue containing the flower debris and 
the distillation water is discharged in the drainage system or spread on the soil around the 
distillation factory. However, rose oil distillation wastewater (RODW) represents a serious 
environmental problem due to the high content of polyphenols which are difficult to decompose 
and which are considered bio-pollutants when discarded into the rivers. In a recent approach 
we developed a method to separate RODW into a polyphenol depleted water fraction and a 
polyphenol enriched fraction RF20-(SP-207) [3]. 
It is well known that polyphenols and especially flavonoids possess a wide range of 
pharmacological activities, such as anti-oxidant, free-radical scavenging, anti-cancerous, anti-
inflammatory, anti-mutagenic, anti-proliferative and anti-depressive effects [4]. 
One of the major difficulties of elucidating the health effects of polyphenols is their 
unfavourable pharmacokinetic profile since it is well known that especially flavonoids are 
heavily metabolized by colonic microorganisms [5]. The active compounds may not be the 
native polyphenols found in food, which are most often tested in in vitro studies; they are more 
likely to be metabolites [6]. These considerations make the development of a value added 
polyphenol based dietary supplement for oral intake difficult. To circumvent issues related to 
the low oral bioavailability of polyphenols a topical application is the preferential form of 
treatment.  
Taking these points into consideration, it was the initial focus of the present project to 
characterize RF20-(SP-207) for pharmacological effects such as anti-inflammatory, anti-
proliferative and anti-migratory, since these activities of polyphenols from various natural 
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sources are well documented [7]. In a recent bioassay-guided approach, a further purified 
fraction augmented in quercetin and ellagic acid as well as the corresponding pure compounds 
were identified as major active compounds [8]. It was therefore of interest, to investigate their 
contribution to possible anti-proliferative and anti-migratory effects in addition. 
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Results 
Investigating cell viability based on the MTT-assay, a significant decrease of cell viability at 
higher concentrations of RF20-(SP-207) was revealed. RF20-(SP-207) in concentrations of 100 
and 200 µg/mL caused a significant decrease of conversion of the tetrazolium salt into the 
water-insoluble formazan compared to the untreated control (75 and 60%; Figure 1A). Albeit 
not significant, the 10 and 50 µg/mL treatment caused a reduction in cell viability by less than 
20%. By comparing the four fractions F(I)-(IV) of RF20-(SP-207), there was no significant 
reduction determined (Figure 1B). Nevertheless, a decreased viability could be demonstrated 
for F(IV) in the concentration of 100 µg/mL (85% viability compared to control; Figure 1B). 
Further analysis of F(IV) in concentrations of 10, 50, and 100 µg/mL resulted in a significant 
decrease of cell viability at 50 and 100 µg/mL (80 and 70%, respectively; Figure 1C). The 
discrepancy between the two results of Figs. 1B and C can be ascribed to the normalization on 
two different controls and the limited intrinsic precision of this method. 
 
 
Figure 1: Effects on cell viability of A RF20-(SP-207), B F(I)-(IV) and C F(IV). Results expressed as Mean ± SD 
of three independent experiments. **p<0.01, ***p<0.001 vs. untreated control group. 
 
The MTT assay is one of the standard techniques for assessment of cell viability. However, 
several studies have shown that some plant extracts and redox-active polyphenols interfere with 
the MTT assay since they directly reduce the tetrazolium salt even in absence of cells [9-11]. 
Because of inaccuracies inherent in the MTT-method, the ATP assay was chosen as an 
alternative to assess viability. Hence, HaCaT keratinocytes were treated with RF20-(SP-207) 
or F(IV) for 24 h. Subsequent measuring of the ATP levels provided information about the 
survival- and death-rate of the cells under influence of the corresponding substances. RF20-
(SP-207) decreased cell viability of about 20% in the concentrations of 10 and 50 µg/mL 
compared to the untreated control while the concentration of 100 µg/mL caused a massive drop 
in cell viability to 45% (Figure 2).  
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 The different relative values of the 
MTT and ATP assays are the results 
of the nature of the target that are 
measured. Wang et. al. [10] 
demonstrated that depending on the 
method, the curves are of certain 
steepness and thus, are not 
superimposable. F(IV) acted similar 
to RF20-(SP-207), albeit the lower 
concentration of 10 µg/mL did not 
influence the ATP level 
significantly. Based on these data, RF20-(SP-207) and F(IV) were used in a concentration of 
10 µg/mL for subsequent experiments since it did not severely affect cell viability. Quercetin 
(50 µM) and ellagic acid (1 and 10 µM) also had no significant effect on cell viability (data not 
shown). The intracellular ATP-level is dependent on the phosphorylation of ADP by the ATP 
synthase. ATP is therefore a better marker for cell viability because of its presence in 
metabolically active cells. ATP levels decrease rapidly when the cells undergo necrosis or 
apoptosis. Mitochondrial ATP synthesis does not occur if the proton motive force is absent. 
Thus, the MTT assay can give false positive effects when uncoupling agents and polyphenolic 
compounds are used [12].  
The keratinocytes' proliferation rate was determined by the BrdU-assay. Additionally to RF20-
(SP-207), the PI3K/mTOR-inhibitor NVP-BEZ235 (100 nM) and the PI3K-inhibitor 
LY294002 (10 µM), as well as quercetin (50 µM) and ellagic acid (1 µM) were applied and 
their outcomes compared to an untreated control. RF20-(SP-207) significantly decreased BrdU 
incorporation at 5 and 10 µg/mL (63% vs. control) while NVP-BEZ235 and LY294002 resulted 
in a DNA-synthesis inhibition of 56% and 57% (Figure 3A). The IC50 of RF20-(SP-207) was 
determined at 9.78 µg/mL (Figure 3B). Comparing these results with those of F(IV), inhibition 
of thymidine incorporation was similar; 10 µg/mL provoked a proliferation decrease of 28 % 
correlating to 10 µg/mL of RF20-(SP-207) (Figure 3C). Ellagic acid (1 µM) reduced the BrdU 
incorporation by 14 %, followed by the significant effect of quercetin (50 µM) with a drop of 
25 % (Figure 3A/D). 
Figure 2: Effects of RF20-(SP-207) and F(IV) on A) the cellular 
ATP-level. Results expressed as Mean ± SD of three 
independent experiments. **p<0.01, ***p<0.001 vs. untreated 
control group or lysis buffer, respectively. 
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Figure 3: A Inhibition of the BrdU incorporation in de novo synthesized cellular DNA by RF20-(SP-207); B 
IC50 determination of the BrdU inhibition by RF20-(SP-207); C comparison of RF20-(SP-207) and F(IV) on 
BrdU inhibition. D Inhibition of the BrdU incorporation in de novo synthesized cellular DNA by ellagic acid 
at a concentration of 1 µM. Results expressed as Mean ± SD of three independent experiments. **p<0.01, 
***p<0.001 vs. untreated control. 
 
 
 
 
 
Figure 4: Effects of RF20-(SP-207), quercetin, ellagic acid, NVP-BEZ235 and LY294002 on the cellular 
VEGF production level in A unstimulated HaCaT keratinocytes and B TNF-α (20 ng/mL) stimulated 
keratinocytes for 24 h; effects of F(IV) in C unstimulated HaCaT keratinocytes and D TNF-α (20 ng/mL) 
stimulated keratinocytes for 24 h at 20 ng/mL. Results are expressed as Mean ± SD of three independent 
experiments. *p<0.1, **p<0.01, ***p<0.001 vs. TNF-α stimulated control<, ###p<0.001 vs unstimulated 
control. 
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Treatment of HaCaT cells with RF20-(SP-207) significantly decreased VEGF secretion in 
concentrations of 10 and 50 µg/mL (Figure 4A). The effect was comparable to that of the 
positive controls LY294002 (10 µM) and NVP-BEZ235 (100 nM). While quercetin (50 µM) 
only had a moderate effect on VEGF secretion, a significant suppression of VEGF release was 
observed for ellagic acid (1 µM). Stimulation of HaCaT cells with TNF-α (20 ng/mL) 
significantly triggered release of VEGF 2-fold compared to control cells (Figure 4B). 
Pretreatment with RF20-(SP-207) significantly inhibited TNF-α stimulated VEGF secretion 
dose dependently. Interestingly, ellagic acid, quercetin, NVP-BEZ235, and LY294002 could 
not reduce VEGF-secretion after TNF-α stimulation (Figure 4B). For F(IV) experiments were 
repeated using the same setup. In case of the unstimulated setup, F(IV) at 10 µg/mL could 
significantly decrease VEGF of the untreated control (Figure 4C). Similar effects were observed 
in the stimulated setup where F(IV) at 10 µg/mL could significantly decrease VEGF secretion 
compared to the stimulated control.  
 To further substantiate anti-proliferative effects of RF20-(SP-207) and F(IV), the Cell Death 
Detection ELISAPLUS photometric enzyme immunoassay was used to detect internucleosomal 
degradation of genomic DNA during apoptosis (Figure 5). Cells were treated with the positive 
control anisomycin (10 μM), NVP-BEZ235 (100 nM), LY294002 (10 μM), RF20-(SP-207), 
F(IV) (both at 10 μg/mL), quercetin (50 μM), ellagic acid (1 μM) and compared to an untreated 
control. After 24 hours, the enrichment of histone-complexed DNA fragments in the cells 
cytoplasm was determined spectrophotometrically. Anisomycin inhibits the peptidyl 
transferase of the 80s ribosome system and thereby induces apoptosis. Treatment with this 
substance at 10 µM yielded a 16-fold increase of cell death rate in HaCaT cells.  NVP-BEZ235, 
LY294002 and ellagic acid failed to induce significant DNA damage at the used doses. Non-
toxic doses of quercetin and RF20-(SP-207) increased DNA fragmentation by 11-fold; F(IV) 
by 7-fold, respectively. 
 Figure 5: Quantification of DNA-histone-complexes expressed as the enrichment factor (equation of NVP-
BEZ235, LY294002, quercetin, ellagic acid, RF20-(SP-207) and F(IV) compared to an untreated control 
serving as a (-)-control and anisomycin posing a (+)-control. Results expressed as Mean ± SD of two 
independent experiments. **p<0.01, ***p<0.001 vs. untreated control. 
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 Time lapse cell migration assays were performed by placing silicone inserts into 12-well plates, 
thereby inducing a gap in the monolayer. The migration process started after subsequent 
removal of the inserts. Cell migration was observed for 24 hours and pictures were taken every 
30 minutes. For better data presentation, the 24 h observation period was divided into five time 
points (0; 6; 12; 18; 24h) to demonstrate closure of a 450 µm cell gap (Figure 6 and Table 1). 
Figure 6 shows representative images and gap closure values only from a single experiment. 
All values presented in Table 1 are the outcomes of at least three independent experiments and 
presented as Mean ± SD.  At t = 24 h, a gap closure of 93.29 ± 12.86% was reached for the non-
supplemented control (Table 1). Medium supplemented with 2% FCS was used as positive 
control. In contrast to the non-supplemented control, the gap was closed almost to 100% already 
after 12 h (95.18 ± 9.63%). RF20-(SP-207) exerted distinct inhibitory effects on cell migration 
(at t = 24h 51 ± 17.57%) in comparison to the untreated control. F(IV) provoked even stronger 
effects. At 10 µg/mL the migration speed slowed down clearly (18.62 ± 4.20 % closure at t = 
24h). NVP-BEZ235 (100 nM) and LY294002 (10µM) were selected to include migration-
modulators of different modes of action [13, 14]. The two reference compounds NVP-BEZ235 
and LY294002 generated a clear impairment on cell migration versus the untreated control 
(approx. 64% and 39% closure at t = 24h, respectively; Figure 6; Table 1). The 
phosphatidylinositol-3-kinase inhibitor LY294002 was the strongest among the references in 
terms of inhibition of cell migration. The effects of RF20-(SP-207) and F(IV) on cell migration 
were more comparable to those of LY294002. Further, the effects of quercetin and ellagic acid 
 
 
 
 
 
 
 
Figure 6: Cell migration in response to an 
artificial injury using long term, time-lapse 
imaging interval snap-shots of predefined 
positions in the wound gap (450 μm). Pictures 
show the momentum at 0 h, 6 h, 12 h, and 24h. 
HaCaT cells were treated with the control 0% 
FCS, the positive control 2% FCS as well as 
RF20-(SP-207) (10 μg/mL), F(IV) (10 
μg/mL), quercetin (50 μM), ellagic acid (1 
µM), LY294002 (10 µM) and NVP-BEZ235 
(100 nM). 
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as major constituents of F(IV) were examined. Both compounds had different effects on cell 
migration. While quercetin in a concentration of 50 µM showed a strong anti-migratory effect 
(44.66 ± 19.62% gap closure after 24h), ellagic acid in a concentration of 1 µM did not markedly 
affect cell migration and remained on the control level. 
gap closure % [mean ± SD] 
 0h 6h 12h 18h 24h 
Control 0 43.27 ± 14.26 74.85 ± 21.37 89.56 ± 16.62 93.29 ± 12.86 
Control 2% FCS 0 62.52 ± 26.96 95.18 ± 9.63 100.00  100.00  
NVP-BEZ235 100 nM 0 13.73 ± 2.75 26.12 ± 2.78 45.60 ± 7.60 63.82 ± 13.52 
LY294002 10 µM 0 11.90 ±4.00 20.78 ± 2.83 28.06 ± 7.00 38.69 ± 2.71 
Quercetin 50 µM 0 17.24 ± 5.84 34.10 ± 9.33 41.00 ± 16.20 44.66 ± 19.62 
Ellagic acid 1 µM 0 31.75 ± 11.74 69.90 ± 16.75 96.93 ± 4.44 99.10 ± 1.91 
RF20-(SP-207) 10 µg/mL 0 17.85 ±1.87 29.86 ± 6.81 41.44 ± 12.31 51.00 ± 17.57 
F(IV) 10 µg/mL 0 8.54 ± 2.13 12.29 ± 2.20 16.55 ± 3.00 18.62 ± 4.20 
 
 
 
 
To further determine the effects of RF20-(SP-207) and F(IV) on growth inhibition, 
morphological changes were examined under a phase-contrast microscope. Cells treated with 
anisomycin clearly showed apoptotic morphology (fragmented nuclei, membrane blebbing) 
(Figure 7).  The images also show obvious morphological changes when HaCaT cells were 
treated with RF20-(SP-207) and F(IV) with visible apoptotic vesicles although the effects 
were less pronounced compared to the anisomycin-treated cells. 
Table 1: Cell migration in response to an artificial injury. Time-lapse microscopy was performed and 
snapshots were taken every 30 min. during 24h, whereof values for statistical calculation were used from 
images at t = 0h, 6h, 12h, 18h, and 24h. Gap size was calculated by utilizing the software Image J including 
the wound healing tool-macro. Detected spaces were converted into percent-ages; 0% refers to no movement 
of cells, 100% depicts a total gap closure. Values represent the mean ± SD of the closed area in percent of 
the primordial cell gap induced by an insert calculated by at least three independent experiments.  
 
 
Figure 7: Morphology of 
HaCaT cells treated with 
the control, RF20-(SP-
207) (10 μg/mL), F(IV) 
(10 μg/mL), ellagic acid 
(1 μM), quercetin (50 
μM), and anisomycin 
(positive control, 10 μM) 
for 24 h under phase 
contrast microscopy (20× 
objective). 
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Discussion 
In the present study, the spontaneously immortalized human keratinocyte cell line HaCaT was 
used to examine potential anti-proliferative activities of RF20-(SP-207) and its concentrated 
fraction F(IV). Despite omitting a detailed cell cycle analysis by flow cytometry, it was 
demonstrated that RF20-(SP-207) and F(IV) effectively inhibited proliferation and migration 
of human keratinocytes as shown by the results of the BrdU incorporation assay and the time 
lapse microscopy data. The effects of RF20-(SP-207) and F(IV) can be explained by presence 
of quercetin and partly by ellagic acid since both compounds are the major compounds thereof. 
In addition, it was shown that RF20-(SP-207) and F(IV) significantly inhibited basal and TNF-
α induced stimulation of vascular endothelial growth factor (VEGF) in a concentration range 
that did not affect normal cell viability. The observed effects are further comparable to the 
PI3K-inhibitor LY294002 and the dual PI3K/mTOR-inhibitor NVP-BEZ235 which both were 
used as positive controls. 
In the epidermal layer of the skin, keratinocytes represent the major cell type. In response to 
endocrine and immune triggers, keratinocytes can release various cytokines such as IL-6 or IL-
8 but also release VEGF [15]. When the balance between growth, differentiation and death is 
altered in keratinocytes, they undergo hyper-proliferation, abnormal differentiation and 
inflammatory infiltration. This will result in the pathological manifestation of psoriasis, which 
is a chronic, inflammatory skin disease, characterized by hyper-proliferation and aberrant 
differentiation of keratinocytes [16]. Approximately 1-3% of the world population is affected 
by this chronic skin disease. An improved understanding of the molecular basis underlying 
psoriasis in recent years has led to the introduction of anti-proliferative and TNF-α blocking 
biologicals (e.g. etanercept, adalimumab) as an effective treatment alternative for this disease 
[16]. Although these therapies are highly effective, many patients experience serious side 
effects, most prominently a higher risk of infections [17]. In addition, these compounds require 
invasive administration such as subcutaneous or intravenous injections. However, for patients 
with mild symptoms a less invasive approach is desired. Therefore, a topical regimen acting 
locally by influencing cell fate, viability and proliferation, is a desirable treatment approach. 
In the present study, it was shown that the polyphenol enriched fraction of rose oil distillation 
water RF20-(SP-207) and a purified fraction of F(IV) not only inhibited cell proliferation but 
also significantly suppressed basal and TNF-α stimulated VEGF secretion. TNF-α is a pro-
inflammatory cytokine that plays a key role in the pathogenesis of psoriasis [18]. TNF-α levels 
are elevated in psoriasis and play an important part in T-cell proliferation and disease 
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pathogenesis [19]. It stimulates keratinocytes to release VEGF, which is a potent stimulator of 
cell proliferation, migration, and survival [20]. VEGF is not only a key regulator of cutaneous 
angiogenesis, where it contributes to several physiological and pathogenic processes in the skin. 
These include for instance cancer development, hair growth, psoriasis, and wound healing. The 
signal protein also increases the tissue permeability during the onset of an inflammation process 
and therefore executes a multimode function (for review see [21]). Increasing experimental 
evidence has shown the effectiveness of anti-VEGF strategy for the treatment of psoriasis [22]. 
Many existing psoriasis therapies influence the production or function of VEGF. However, the 
clinical use of current VEGF inhibitors is limited due to a number of potentially serious side 
effects [23]. 
Our findings that RF20-(SP-207) and F(IV) significantly reduce basal and TNF-α stimulated 
VEGF secretion in human keratinocytes represent therefore a promising treatment option that 
is worth being further investigated. Since the effects of F(IV) resemble that of RF20-(SP-207) 
it can be speculated that ingredients only found in this fraction are responsible for the observed 
effects. As mentioned earlier, F(IV) contains quercetin and ellagic acid as major constituents.  
The anti-proliferative and cell migration inhibitory properties of both compounds have been 
studied in a number of cell types [24, 25]. In particular, it has been shown that ellagic acid 
inhibits VEGF-induced phosphorylation of VEGFR-2 in endothelial cell as well as PDGF-
induced phosphorylation of PDGFR in smooth muscle cells [25]. Furthermore, ellagic acid 
inhibited VEGF-induced migration of endothelial cells. The authors demonstrated that ellagic 
acid presented a greater selectivity for normal cells than for tumor cells and concluded that the 
anti-angiogenic effects of ellagic acid can be explained by dual inhibition of VEGF and PDGF 
receptors [25]. 
Wang et al. [26] reported that ellagic acid significantly inhibited a series of VEGF-induced 
angiogenesis processes including proliferation, migration, and tube formation of endothelial 
cells. Ellagic acid further inhibited VEGFR-2 tyrosine kinase activity and downstream 
signaling pathways such MAPK and PI3K/Akt in endothelial cells [26]. 
In the present study ellagic acid significantly inhibited VEGF secretion in unstimulated 
keratinocytes. However, after stimulation with TNF-α no reduction of VEGF release was 
observed. Only very few literature data are available that report effects of ellagic acid in 
keratinocytes and they focus on either the anti-inflammatory or anti-cancer activities [27, 28]. 
The observed anti-angiogenic properties of ellagic acid in keratinocytes in the present study are 
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in line with published data observed in various cancer cells [25, 29]. To our knowledge, this is 
the first time that effects of ellagic acid in TNF-α stimulated keratinocytes were investigated. 
In the present study, ellagic acid - like quercetin - could not reduce VEGF levels induced by 
TNF-α in HaCaT cells. Interestingly, F(IV) which contains both, quercetin and ellagic acid, 
significantly decreased VEGF secretion in TNF-α stimulated cells. It is speculated, that both 
compounds might act synergistically under the chosen experimental conditions. Synergistic 
effects of quercetin and ellagic acid have been reported previously [30]. The authors found that 
a combination of both compounds synergistically induced apoptosis, inhibited cell proliferation 
and reduced cell growth in human leukemia cells.  
The antiangiogenic effects of quercetin targeting VEGF pathways have been investigated 
comprehensively in the literature [31, 32]. In the present study, quercetin lightly affected basal 
VEGF secretion, but did not alter TNF-α stimulated VEGF secretion compared to the stimulated 
control. It has to be emphasized again that in most studies reporting the anti-angiogenic effects 
of quercetin cancer cell lines were used, whereas only a few studies with quercetin and 
keratinocytes exist. Redondo et al. [33] demonstrated that quercetin suppressed the 
incorporation of 3H-thymidine into human keratinocytes and significantly inhibited VEGF 
secretion in basal and EGF- or PMA-treated human keratinocytes. However, the contradicting 
results between the study of Redondo et al. [33] and the current study could possibly be 
explained by different experimental settings – we used TNF-α to stimulate VEGF secretion 
while in the Redondo study VEGF was added to the cells. Although not directly related, Weng 
et al. [34] recently found that luteolin could inhibit TNF-α stimulated VEGF secretion in HaCaT 
cells. The experimental setting in this study was comparable to the one used in the present 
investigation. In a recent study using the same experimental conditions we could show that a 
bamboo leaf extract significantly decreased TNF-α stimulated VEGF production in HaCaT 
cells. Isoorientin was identified as major active substance and dose-dependently decreased 
TNF-α induced VEGF levels [35]. 
Interestingly, F(IV) which contains besides other polyphenols mainly ellagic acid and quercetin 
[8] reduced VEGF secretion under basal and TNF-α stimulated conditions. Since this effect 
resembles that of RF20-(SP-207), it is assumed that the activity is located in this fraction. 
Recent data of our group support this assumption [8]. We further speculate that the overall 
effect on basal and TNF-α stimulated VEGF secretion can be explained by a synergistic effect 
of quercetin and ellagic acid. As mentioned above, such effects have been described in the 
literature and underline the observations in the present study [30].  
 Results and Discussion 
85 
 
Cell migration is an extraordinary complex mechanism mostly driven by a dynamic interplay 
of random motion, chemokinesis and chemotaxis [36]. It was shown in the present study that 
RF20-(SP-207) and F(IV) have been similar in their impact on cell migration at 10 µg/mL, 
provoking a severely retarded gap closure comparable to the reference compound LY294002. 
As mentioned above, the major constituents of RF20-(SP-207) and F(IV) are quercetin and 
ellagic acid. Both compounds had different outcomes on cell migration in the present 
experiments with quercetin showing more pronounced effects. Cao et al. [31] recently reported 
that quercetin at a concentration of 40 µM strongly inhibited A375, A2058, and B16F10 cell 
migration. Similar results were observed by Prateeshkumar et al. [37] who showed that 
quercetin significantly inhibited VEGF induced migration of HUVEC cells in a dose dependent 
manner with maximum inhibition of cell migration at 40 µM. Several other studies also reported 
a suppression of cell migration by quercetin in various concentration and various cell lines [24, 
38, 39] and our results together with the decreased proliferation as shown in the BrdU 
incorporation assay are in line with these published data. 
The anti-invasive effects of ellagic acid are also well described [25, 29]. Ellagic acid did not 
have a significant effect on cell migration in our study, although the compound reduced basal 
VEGF levels. The slightly different effects between the published results and our data could be 
explained by different treatment responses between cancer cell lines and normal cells. The 
physiological processes of cell migration are different in tumor cell lines because they are 
activated by several pro-migratory factors without stop signals causing an imbalance of signals. 
Due to this imbalance, cancer cell lines can modify their migration mechanisms in response to 
different conditions [40]. It is therefore not unlikely that compounds may differently affect 
pathways between normal and cancer cell lines [41]. Furthermore, ellagic acid is hardly soluble 
in pure aqueous media. DMSO as a solubilizer was used in a max. concentration of 0.1 %, 
which is nontoxic for HaCaT keratinocytes. Taking these issues into account, it was not possible 
to test ellagic acid concentrations higher than 10 µM. 
Another important finding of the present study is that RF20-(SP-207), F(IV) and quercetin 
showed pro-apoptotic effects in addition to the pronounced anti-proliferative activities. It is 
assumed that the anti-proliferative effects of RF20-(SP-207) and F(IV) are a result from a 
cytotoxic effect, and an induction of apoptosis. A similar mechanism has been suggested for 
topical corticosteroids, which are often used in dermatology for their anti-proliferative effects 
[42]. Skin diseases such as psoriasis are characterized by hyper-proliferation and decreased 
apoptosis of epidermal keratinocytes [43]. Thus, RF20-(SP-207) could be developed as a novel 
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non-steroidal therapy directed towards inhibition of cell proliferation and enhancement of 
apoptotic process in psoriasis. 
 
In summary, RF20-207, a polyphenol-enriched fraction of RODW, demonstrated potent 
inhibitory effects on cell proliferation and migration. Fraction (IV), which contains quercetin 
and ellagic acid in significant amounts, resembles the activity of RF20-(SP-207). The effects 
of the individually tested compounds quercetin and ellagic acid, could partly explain the potent 
anti-proliferative and anti-migratory effects of RF20-(SP-207) and F(IV). Their effect could be 
additive or synergistic and more experiments are necessary to clarify the exact mechanism of 
compound interaction. There is an increasing interest in plant-derived compounds for the 
treatment of hyper-proliferative skin diseases because they present safer alternatives when 
compared with synthetic medicines. Although a large number of plant based inhibitors of cell 
proliferation have been reported in the literature they are typically not commercially available. 
Their further clinical evaluation as active ingredients for dermatological purposes is often 
limited, since large amounts are usually needed for incorporation in topical formulations. Our 
approach therefore could close a gap in the raw material supply chain since large quantities of 
this highly active 'bioproduct' of rose oil distillation water is easily accessible. Appropriate 
topical formulations have to be developed and the effectiveness and safety has to be further 
evaluated.  
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Material and Methods 
Chemicals and Reagents 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid (MTT, purity >98%), adenosine 
5'-triphosphate (purity >99%), sodium dodecyl sulfate (SDS), acetic acid (purity >99.7%), 
anisomycin (purity >98%), ellagic acid (EA, purity >95%) and dimethyl sulfoxide (purity 
>99.5%; DMSO) were purchased from Sigma-Aldrich (Buchs, CH). 5-bromo-2'-deoxyuridine- 
(BrdU), human VEGF ELISA kits, Dulbecco's Phosphate buffered saline [-] CaCl2; [-] MgCl2, 
Trypsin-EDTA 0.5% (10x), LY294002 (PI3K-inhibitor) and NVP-BEZ235 (dual PI3K/mTOR-
inhibitor) were provided by LubioScience (Luzern, CH). E. coli-derived recombinant human 
TNF-α (purity >97%) was purchased from R&D Systems (Abingdon, UK). Quercetin 
dehydrate (purity >99%) was purchased from Extrasynthese (Genay, FR). CellTiter-Glo 
Luminescent Cell Viability Assay was obtained from Promega (WI, USA). Rat tail collagen 
type I was provided by Trevigen Inc. (Gaithersburg, MD, USA). Cell Death Detection 
ELISAPLUS Kit was from Roche Diagnostics (Rotkreuz, CH). 
 
Cell culture 
Human non-tumorigenic HaCaT keratinocytes (Cell Line Services, Eppelheim, Germany) were 
maintained in Dulbecco's Modified Eagle's Medium high glucose 1x supplemented with 1% 
(v/v) Penicillin 10.000 U/mL / Streptomycin 10.000 µg/mL and 10% (v/v) heat inactivated fetal 
calf serum (FCS) (LubioScience, Luzern, Switzerland) at 37 °C in a humidified atmosphere 
containing 5% CO2. Experiments were routinely conducted at approximately 80-90% 
confluency [44]. All experiments were carried out between passages 32 and 70. Periodical tests 
on mycoplasma contaminations were negative. All compounds were used in a final DMSO 
concentration of max. 0.1% (v/v). Concentrations of LY294002 (10 µM), NVP-BEZ235 (100 
nM) and anisomycin (10 μM) which were used as reference compounds were chosen according 
to published data [13, 45, 46].The concentration of quercetin was also selected based on 
published data [30, 37]. Ellagic acid could not be used in concentrations higher than 10 μM 
because of solubility issues (a final concentration of 0.1% DMSO would have been exceeded 
which led to cell toxicity). 
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Plant material and extract preparation 
Wastewater obtained after distillation of full-blown R. damascena flowers was obtained from 
the distillery of the Institute of Roses, Essential and Medicinal Crops (IREMC) in Kazanlak, 
Bulgaria, in June 2013. Wastewater was filtered through a cheese-cloth to afford RODW which 
was stored at +4°C in 10 L plastic bottles. RF20-(SP-207) was prepared from RODW as 
described in [3]. Fractions (I)-(IV) were obtained and phytochemically characterized as 
described in [8]. An extensive phytochemical description of RF20-(SP-207) and F(IV) is 
published in [3]. RF20-(SP-207) mainly consisted of phenolic compounds, such as 
isoquercitrin, kaempferol, quercitrin, rutin, astragalin, multiflorin A, ellagic acid, and several 
kaempferol and quercetin glycosides [3]. F(IV) mainly consisted of ellagic acid, quercetin, and 
kaempferol [8]. A voucher specimen of RODW_June2013 is stored at -20°C at the Institute for 
Pharma Technology, School of Life Sciences, FHNW. 
 
Cell viability assay 
Cell viability was assessed by conducting the MTT-test. 200 µL of a HaCaT cell suspension 
was seeded into sterile 96-well plates at a concentration of 1.5x105 cells/mL. After an 
incubation time of 24 hours (37 °C, 5% CO2), the medium containing 10% FCS was discarded 
and the plate was washed with 200 µL/well phosphate buffer saline (PBS). RF20-(SP-207) was 
tested in concentrations of 10, 50, 100 and 200 µg/mL. Fractions (I)-(IV) were tested in 
concentrations of 10 and 100 µg/mL, respectively. After an incubation period of 24 hours and 
a washing step with PBS, 10 µL of MTT-solution (5 mg/mL PBS) dissolved in 100 µL DMEM 
was added and incubated for another 2 hours. The liquid was aspirated before adding 100 µL 
of the cell-lysis buffer consisting of 99.4% DMSO, 0.6% acetic acid and SDS 0.1 g/mL. The 
optical density was read at 500 nm on a microplate reader (SpectraMax M2e, Molecular 
Devices, Sunnyvale, U.S.A.). The viability was calculated according to the equation: 
 
(1) 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 [%] = 100 ∗  
𝑂𝐷500𝑛𝑚(𝑠𝑎𝑚𝑝𝑙𝑒)−𝑂𝐷500𝑛𝑚(𝑁𝑜𝐶𝑒𝑙𝑙𝑠)
𝑂𝐷500𝑛𝑚(𝑐𝑜𝑛𝑡𝑟𝑜𝑙𝑚𝑒𝑎𝑛)−𝑂𝐷500𝑛𝑚(𝑁𝑜𝐶𝑒𝑙𝑙𝑠)
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ATP Assay 
The CellTiter-Glo Luminescent Cell Viability assay was carried out according to the 
manufacturer's protocol. The following alterations were made: cells were grown in a 
transparent, sterile 96-well plate at a density of 1.5x105 cells/mL. After an incubation period of 
24h (37 °C, 5% CO2), cells were washed with PBS, subsequently treated accordingly with 100 
µL solution and incubated for another 24h. 100 µL of CellTiter-Glo reagent was then added to 
each well resulting in a 1:1 dilution. The sample plates were agitated for 2 min by an orbital 
shaker and incubated for 10 min. 100 µL of each well was then transferred to a white, opaque 
sterile 96-well plate and immediately read by a microplate reader (SpectraMax L, Molecular 
Devices, Sunnyvale, U.S.A.). 
 
Cell proliferation assay (BrdU) 
Samples for the 5-bromo-2'-deoxyuridine (BrdU) cell proliferation assay were prepared similar 
to the MTT-test. The assay was conducted according to the manufacturer's protocol. Two hours 
before the end of the corresponding period, BrdU reagent (10 μM, 10μL) was added into all 
wells except the unstained control. After discarding the medium, 200 μL of a fixing/denaturing 
solution was added and incubated for another 30 min. Subsequently, the liquid was exchanged 
by the primary anti-BrdU monoclonal antibody and incubated for 1h. Subsequently, the 
unbound antibody was washed off and horseradish peroxidase-conjugated goat anti-mouse IgG 
was added, which binds to the detector antibody. Finally, 50 μL of 3,3’,5,5’’-
tetramethylbenzidine (TMB) substrate was added and converted by the peroxidase conjugate 
and the reaction was stopped by 2.5 N sulfuric acid stop solution before the plate was read at 
450 nm wavelength using a plate reader (Spectramax i3x Multimode detection platform, 
Molecular Devices, Sunnyvale, U.S.A.). The IC50, i.e. the concentration of the extract resulting 
in 50% inhibition of BrdU incorporation was calculated from dose-response curves by non-
linear regression analysis using GraphPad Prism version 6.01 (GraphPad software Inc., USA). 
 
Measurement of vascular endothelial growth factor secretion 
The experimental setup including the TNF-α concentration was chosen according to Park et al. 
[47], with some modifications. For unstimulated samples, cells were seeded into 12-well plates 
at a density of 1.5x105 cells/mL. After an incubation time of 24 hours (37 °C, 5% CO2), DMEM 
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was discarded, cells were washed with 1mL/well PBS. Samples were prepared as described 
above. To assess the basal secretion of VEGF in keratinocytes, DMEM with 0% FCS was 
applied as a control. In contrast, all wells of stimulated cells were supplemented with TNF-α 
20 ng/mL and substances accordingly and incubated for 24 hours. Supernatants were stored in 
sterile micro centrifuge tubes and deep-frozen (-20 °C) immediately. The VEGF-ELISA was 
exerted according to manufacturers' instructions. Absorbance was measured at 450 nm using a 
microplate reader (Spectramax i3x Multimode detection platform, Molecular Devices). 
 
Cell migration assay 
After placing the cell culture inserts in the 12-well dishes, the HaCaT keratinocytes were seeded 
at a concentration of 1.5x105 cells/mL into collagen-coated wells and bred for 24 h (37 °C, 5% 
CO2), whilst the cells reached confluence. The inserts were removed causing a gap of ca. 450 
μm. After washing the cells with 1 mL PBS, the wells were charged accordingly with the test 
compounds in different concentrations. Medium supplemented with 2% FCS served as a 
positive control. Long-term, time-lapse imaging was performed using the Olympus IX83 
automated inverted microscope platform for live cell imaging (Olympus Corporation). Interval 
snapshots (every 30 min.) of predefined positions in the gap during 24h were taken using the 
Olympus software package cellSens Dimension 1.81. All stacks of recorded images consisted 
of 49 pictures, whereof 5 pictures were extracted to display the momentum at t= 0, 6, 12, 18 
and 24 h. To calculate the size of the gaps over time, post-analysis of the snapshots was 
conducted by utilizing the software Image J (version 1.49q) including the wound healing tool-
macro© (written by Volker Baecker 2010-2012, Nathalie Cahuzac and Virginie Georget). 
Therefore, detected spaces were converted into percentages; 0% refers to no movement of cells, 
100% depicts a total gap closure. 
 
Cell morphology and DNA fragmentation 
The Cell Death Detection ELISAPLUS photometric enzyme immunoassay was used for the 
relative quantification of cytoplasmic histone-complexed DNA fragments (mono- and 
oligonucleosomes) after induction of apoptosis or when released from necrotic cells. The assay 
was performed according to the manufacturer's instructions. Therefore, 1.5 x 105 cells/mL were 
seeded into a 96-well plate and incubated for 24 hours. Subsequently, the supernatant was 
discarded and the cells were lysed to obtain the cytoplasmic fraction. 20 µL of this fraction was 
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transferred to a streptavidin coated 96-well plate and 80 µL of an immunoreagent provided by 
the kit was added. After an incubation period of 2 hours, the wells were washed with 300 µL 
of incubation buffer per well. Finally, absorbance was measured at 490 nm (Spectramax i3x 
Multimode detection platform, Molecular Devices). The rate of apoptosis is reflected by the 
enrichment (fold increase) of mono- and oligonucleosomes accumulated in the cytoplasm and 
was calculated according to the formula [14]:  
 
(2) 𝐸𝐹𝐶𝑒𝑙𝑙 𝐷𝑒𝑎𝑡ℎ 𝐸𝑙𝑖𝑠𝑎 =
𝑂.𝐷.𝑠𝑎𝑚𝑝𝑙𝑒
𝑂.𝐷.̅̅ ̅̅ ̅̅ 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
 
Results are expressed as mean ± SD values of triplicates of two independent experiments. For 
the determination of cell morphology, cells were placed at a density of 1.5 x 105 cells/mL into 
a 12-well plate and then RF20-(SP-207), F(IV) (both at 10 µg/ml, respectively), ellagic acid (1 
µM), quercetin (50 µM) and anisomycin (positive control, 10 µM) were added to the wells and 
incubated for 24 h. Cells in each well were examined and photographed under a phase-contrast 
microscope by using a 20 x objective. 
 
Data analysis 
Data are shown as mean ± SD. All experiments were performed minimum in triplicates, and 
each experiment was repeated at least three times. Statistical analysis of data was carried out 
by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test 
using the software package GraphPad Prism (version 6.01, GraphPad Software Inc). In all 
cases, differences were considered significant if p < 0.05. The IC50 of RF20-(SP-207) was 
calculated from dose-response curves by non-linear regression analysis using GraphPad Prism 
software.  
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Supporting Information 
Detailed information about the preparation and characterization of the investigated 
compounds can be found in the supporting information, which is an excerpt from [8] and [3]. 
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Preparation and characterization of the investigated compounds 
1. Column chromatography and TLC analysis 
Column chromatography was performed on a Sephadex® LH-20 column (100 x 5.5 cm 
I.D.) using 90% methanol as mobile phase, at a flow rate of 2 ml/min. A portion of the 
RF-SP207 resin extract (6.8 g) was dissolved in 60 ml 80% methanol and loaded into the 
column. Fractions were collected every 10 min using a SuperFrac autosampler (GE 
Healthcare). A total of 300 fractions were collection in glass tubes and combined to 12 
main fractions based on TLC patterns. Four additional late eluting fractions were collected 
in flasks giving rise to a total of 16 main fractions: F1 (1-74, 1.32g), F2 (75-88, 0.22g), F3 
(89-104, 0.40g), F4 (105-110, 0.17g), F5 (111-122, 0.64g), F6 (123-130, 0.31g), F7 (131-
136, 0.28g), F8 (137-152, 0.42g), F9 (153-174, 0.26g), F10 (175-194, 0.23g), F11 (195-
226, 0.45g), F12 (227-300, 0.56g), F13 (0.19g), F14 (0.47g), F15 (0.07g) and F16 (0.07g). 
TLC analysis of fractions was performed on precoated silica gel 60 F254 plates (Merck) 
with a mobile phase composed of ethyl acetate/formic acid/glacial acetic acid/water 
(100/11/11/26). Detection was at UV 254 and 366 nm. Spots were visualized at UV-366 
nm after spraying 1% methanolic Naturstoffreagenz A followed by 5% ethanolic PEG-
4000.  Fractions F1 to F16 were combined based on HPLC and TLC data to give four pool 
fractions I to IV in order to simplify pharmacological testing. Fractions F1 and F2 were 
combined in pool “I”, fractions F3, F4 and F5 in pool “II”, fractions F6, F7, and F8 in 
pool “III”, fractions F9 to F16 in pool “IV” (Figure 1S). 
 
2. Compound purification  
Compounds 1 to 14 were purified from Sephadex® LH-20 fractions F1 to F16 by 
preparative HPLC. The prep HPLC system consisted of a SCL-10VP controller, LC-8A 
binary pumps, a UV-Vis SPD-M10A VP detector and Class-VP 6.12 software (all 
Shimadzu). The mobile phase consisted of water (solvent A) and acetonitrile (solvent B) 
with the exception of fraction 12 where 0.1% formic acid was added to both solvents. The 
flow was set to 20 ml/min. Equilibration time between the injections was 10 min. UV 
spectra were recorded from 200 to 400 nm. Separations were performed on a SunFire Prep 
C18 OBD (30 × 150 mm, 5 µm, Waters) column equipped with a SunFire Prep guard column 
(19 x 10 mm, 5 µm, Waters). Preparative HPLC was performed under following isocratic 
conditions:  20% ACN for F1, 22% ACN for F3, 25% ACN for F6 and F8, 30% ACN for 
F4 and 22% + 0.1% formic acid for F12 and compounds were isolated as previously 
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described [3]. Quercetin (16) and Kaempferol (15) were major peaks of F13 and F12 
respectively and their identity was confirmed by co-chromatography of reference 
compounds as previously described [3]. 
3. HPLC-ELSD-DAD-MS analysis 
Analytical HPLC analyses of fraction I-IV were performed on a LC-20AD instrument 
system (Shimadzu) equipped with a SPD-M20A PDA detector, an evaporative light 
scattering detector (ELSD) serie 3300 (Alltech) and a LCMS-8030 detector (Shimadzu). 
For the ELSD, N2 flow was 2.5 L/min, and evaporation temperature was 60 °C. The mobile 
phase consisted of 0.1% formic acid (solvent A) and ACN + 0.1% formic acid (solvent B) 
and the flow was set to 0.4 ml/min. Separations were performed on a C18 SunFire
TM column 
(3.0 x 150mm, 3.5 μm, Waters) equipped with a guard column (3.0 x 20 mm, 3.5 μm, 
Waters) which were thermostatted at 40 °C. Each sample was prepared at a concentration 
of 3.5 mg/ml and 10 μl was injected. The following gradient was used; 10%B isocratic for 
4 min, gradient 4-5min to 17% B, 5-26min to 27%B, 26-27min to 50%B, 27-35min 50%B 
isocratic, 35-36min to 100%B, 36-41min 100%B isocratic, 41-42min to 10%B. All HPLC-
ELSD chromatograms are shown in Figure 2S. 
 
 
 
 
 
 
 
 
 
 
Figure 1S: Based on HPLC and TLC data, pools of four fractions were created. Fractions F1 and F2 were 
combined in pool “I”, fractions 3, 4 and 5 in pool “II”, fractions 6,7, and 8 in pool “III”, fractions 
9,10,11,12,13,14,15 and 16 in pool “IV”. 
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Figure 2S: HPLC-ELSD chromatogram of the LH-20 pooled fractions FI to FIV and crude polyphenol fraction 
RF20-207. 
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Table 1S: Major compounds identified in Fraction I-IV [3]. Identity of quercetin and kaempferol were 
confirmed by co-chromatography of reference compounds. All other compounds were isolated and identity 
confirmed by NMR as previously described [3]. 
  
Peak 
No. 
Compound Rt ESI+ 
Sephadex 
LH20 
Fraction 
Combined 
Fraction 
1 Phenylethyl-glucopyranoside 13.8 285.5 1 I 
2 
Quercetin-3-O-rhamnosylglucoside 
(Rutin) 
15.8 611.2 3 II 
3 Kaempferol 3-O-rutinoside 18.7 595.2 3 II 
4 
Kaempferol-3-O-
glucosylrhamnoside (Multiflorin B) 
23.4 595.2 4 II 
5 
Kaempferol-3-O-
acetylglucosylrhamnoside 
(Multiflorin A) 
30.3 637.2 4 II 
6 
Quercetin-3-O-glucoside 
(Isoquercitrin) 
17.1 465.2 6 III 
7 Kaempferol-3-O-galactoside 19.2 449.1 6 III 
8 
Kaempferol-3-O-glucoside 
(Astragalin) 
20.4 449.1 6 III 
9 Kaempferol-3-O-rhamnoside 26.3 433.1 6 III 
10 
Quercetin-3-O-galactoside 
(Hyperoside) 
16.8 465.2 8 III 
11 
Quercetin-3-O-rhamnoside 
(Quercitrin) 
20.8 449.1 8 III 
12 Kaempferol-3-O-xyloside 22.8 419.1 8 III 
13 Kaempferol-3-O-arabinoside 24.3 419.1 8 III 
14 Ellagic acid 16.3 303.5 12 IV 
15 Kaempferol 31.9 287.2 12 IV 
16 Quercetin 30.8 303.3 13 IV 
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3.3. In Vitro Modulation of Inflammatory Target Gene Expression by a Polyphenol-
Enriched Fraction of Rose Oil Distillation Waste Water 
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Abstract 
Classical production of rose oil is based on water steam distillation from the flowers of Rosa 
damascena. During this process, large quantities of waste water accrue which are discharged to 
the environment, causing severe pollution of both, groundwater and surface water due to a high 
content of polyphenols. We recently developed a strategy to purify the waste water into a 
polyphenol-depleted and a polyphenol-enriched fraction RF20-(SP-207). RF20-(SP-207) and 
sub-fraction F(IV) significantly inhibited cell proliferation and migration of HaCaT cells. Since 
there is a close interplay between these actions and inflammatory processes, here we focused 
on the fractions’ influence on pro-inflammatory biomarkers. HaCaT keratinocytes were treated 
with RF20-(SP-207), F(IV) (both at 50 µg/mL) and ellagic acid (10 µM) for 24 h under TNF-
α (20 ng/mL) stimulated and non-stimulated conditions. Gene expression of IL-1β, IL-6, IL-8, 
RANTES and MCP-1 was analyzed by reverse transcriptase polymerase chain reaction (RT-
PCR) and cellular protein secretion of IL-8, RANTES and MCP-1 was determined by ELISA 
based assays. RF20-(SP-207) and F(IV) significantly decreased the expression and cellular 
protein secretion of IL-1β, IL-6, IL-8, RANTES and MCP-1. The diminishing effects on 
inflammatory target gene expression were slightly less pronounced under TNF-α stimulated 
conditions. In conclusion, the recovered polyphenol fraction RF20-(SP-207) from rose oil 
distillation waste water markedly modified inflammatory target gene expression in vitro, and, 
therefore, could be further developed as alternative treatment of acute and chronic 
inflammation.  
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1.  Introduction 
While acute inflammation can be triggered by either foreign microbial invaders or mechanical 
damage of the skin, chronic inflammation is a result of habitual or environmental factors. By 
the inflammatory response, the organism tries to defeat the trigger by removing necrotic cells 
and tissues damaged from the original insult, and thus, to initiate tissue repair [1]. However, in 
some cases the inflammatory reaction damages the host more than the trigger. Thus, drugs like 
(non-) steroidal anti-inflammatory drugs (NSAID) have been developed to control the course 
of the inflammatory response. Considering its complex cascade, not only a cellular crosstalk is 
crucial, the organism also instantly provides various chemokines and growth factors among 
others [2]. Some pro-inflammatory constituents of this mixture are the tumor necrosis factor 
alpha (TNF-α), IL-1β, IL-6, IL-8, Regulated on Activation Normal T-cell Expressed and 
Secreted (RANTES) and, Monocyte Chemotactic Protein 1 (MCP-1). Taking TNF-α into 
account, its pivotal role attracted much attention to successfully develop several potent 
biosimilars [3]. IL-6 promotes inflammation by inducing neovascularization and hyperplasia, 
which is especially the case for chronic developments [4]. IL-8 is a potent chemoattractant for 
T lymphocytes, neutrophils and eosinophils [5]. IL-1β levels are usually elevated manifold 
during progression of auto-immune diseases in particular [6]. As members of the c-c motif 
family, both RANTES and MCP-1 depict mediators, potent chemo-attractants for macrophages 
and leukocyte activators [7, 8]. Attenuating or deactivating these agents among others as 
alternative or improvement to standard drugs is a desirable objective in the treatment of 
inflammation. In this context, plant derived extracts have gained considerable scientific 
attention.  
Rosa damascena Mill. f. trigintipetala Dieck (Rosaceae) is known for containing a wide 
spectrum of polyphenols and anthocyanidins. While the oil exerts anti-microbial effects for 
instance, polyphenols by the majority are responsible for the medicinal properties such as anti-
HIV, anti-oxidant, anti-tussive, anti-diabetic or anti-plasmodia activity [9]. Nowadays, the 
flowers are annually harvested to extract the essential oil for the cosmetic and food industry 
[10], whereof about 50% of the global share is produced in Bulgaria [11]. Because of its low 
content of essential oils (0.02 % according to Baser et. al. [12]), in each distillation cycle, 
between 500 and 1000 kilogram of rose petals is used, accruing the four-fold quantity of liquid 
waste [11]. The volume of production amounts to approximately 1000-2000 kilogram pure rose 
oil each year. Hence, it not only poses a respectable economic factor, but also a serious 
environmental damage. Rose oil distillation waste water (RODW) contains hydrophilic 
polyphenols, which are considered bio-pollutants [13] and thus, is difficult to decompose. 
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However, up-to-date, the by-product is discharged into the drainage system or spread on local 
soil [14]. For this reason, primarily valorization of a by-product in terms of pharmaceutical 
beneficence attended by a development of a strategy for wastewater management is one 
interesting aspect.  
Agents dissolved in rose oil distillation waste water are compounds like kaempferol, quercetin, 
and ellagic acid and their glycoside derivatives [13, 15-17]. We recently established a strategy 
to separate RODW into a polyphenol depleted and a polyphenol enriched fraction RF20-(SP-
207) [13]. Subsequently, RF20-(SP-207) was submitted to a bioassay-guided fractionation 
using Sephadex LH-20 and was split into four sub-fractions F(I)-(IV) according to their major 
compounds [17]. Based on our previous results [14], we chose F(IV) for further investigation.  
In a former study [14], we reported significant inhibiting effects of RF20-(SP-207) and F(IV) 
on human keratinocytes in terms of proliferation and migration. Since there exists a close 
interplay between these cellular processes and events of inflammation [18], the influence on 
exclusively pro- inflammatory biomarkers was of interest. Hence, the focus of this study was 
to explore the effect of RF20-(SP-207) and F(IV) on transcriptional activity of five different 
key targets in comparison to one of their major single compounds ellagic acid.  
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2.  Experimental 
2.1 Chemicals and Reagents 
Ellagic acid (EA, purity >95%) and dimethyl sulfoxide (purity >99.5%; DMSO) were 
purchased from Sigma-Aldrich (Buchs, CH). Human IL-8 ELISA kit, Dulbecco’s Modified 
Eagle Medium high glucose (1x), Dulbecco's Phosphate buffered saline without CaCl2 and 
MgCl2, Trypsin-EDTA 0.5% (10x), 10.000 Units/mL Penicillin and 10.000 µg/mL 
Streptomycin and heat inactivated calf serum (FCS) were provided by LubioScience (Luzern, 
CH). E. coli-derived recombinant human TNF-alpha (purity >98%), human MCP-1 and 
RANTES ELISA kit were purchased from BioLegend (San Diego, USA). 
 
2.2 Cell Culture 
Human non-tumorigenic HaCaT keratinocytes (Cell Line Services, Eppelheim, Germany) were 
maintained in Dulbecco's Modified Eagle's Medium high glucose 1x supplemented with 1% 
(v/v) Penicillin 10.000 U/mL / Streptomycin 10.000 µg/mL and 10% (v/v) heat inactivated fetal 
calf serum (FCS) at 37 °C in a humidified atmosphere containing 5% CO2. Experiments were 
routinely conducted at approximately 80-90% confluency [19] and carried out between 
passages 55 and 67. Both, RF20-(SP-207) and F(IV) were tested in a concentration of 50 
µg/mL, while ellagic acid was used at 10 µM. Additionally, the substances were individually 
applied in the same concentrations with a supplementation of 20 ng/mL TNF-α. This set-up 
was used to simulate an in vitro inflammatory condition. The results of each experiment were 
compared to an untreated control signifying keratinocytes exposed to medium with 0% serum, 
and a treated control composed of medium with 20 ng/mL TNF-α. Except ellagic acid (DMSO 
concentration 0.125%), all compounds were used in a final DMSO concentration of max. 0.1% 
(v/v), which has been proven harmless for this cell line (data not shown). 
 
2.3 Plant Material and Extract Preparation 
Wastewater obtained after distillation of full-blown R. damascena flowers was obtained from 
the distillery of the Institute of Roses, Essential and Medicinal Crops (IREMC) in Kazanlak, 
Bulgaria, in June 2013. RF20-(SP-207) was prepared from RODW as described previously 
[13]. Briefly, the concentration process includes a filtration process to eliminate suspended 
solids in the wastewater, followed by adsorption of phenolic compounds from RODW onto 
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adsorption resins (XAD and SP). Finally, desorption of the polyphenol fraction from the resin 
matrix was achieved using ethanol and/or aqueous ethanol. The result of the process was a 
wastewater low in soluble organic compounds and an enriched polyphenol fraction (RF20-(SP-
207)). The profile of RF20-(SP-207) was similar to that of RODW, and showed the presence 
of flavonols such as quercetin and kaempferol glycosides as major metabolites [13]. Fractions 
(I)-(IV) were obtained and phytochemical characterized as described in [17]. Extensive 
phytochemical descriptions of RF20-(SP-207) and F(IV) is published in [13, 17]. RF20-(SP-
207) mainly consisted of phenolic compounds, such as isoquercitrin, kaempferol, quercitrin, 
rutin, astragalin, multiflorin A, ellagic acid and several kaempferol and quercetin glycosides 
[13]. F(IV) mainly consisted of ellagic acid, quercetin and kaempferol [17]. A voucher 
specimen of rose oil distillation waste water (#RODW_June2013) is stored at -20°C at the 
Institute for Pharma Technology, School of Life Sciences, FHNW. 
 
2.4 RNA and Real Time Quantitative RT-PCR 
After cell treatment and incubation in 12-well plates, mRNA was extracted using the RNEasy 
Mini Kit by Qiagen (Valencia, USA). Subsequently, mRNA concentration was measured at 260 
nm using the NanoDROP 2000c Spectrometer (Thermo Fischer Scientific) and samples were 
diluted accordingly to a final concentration of 6 ng/µL. Reverse transcription was done in two 
steps utilizing the Biometra T3000 Thermocycler (Göttingen). First, 66 ng of RNA were 
charged with 80 ng Oligo-dT primers/reaction (Qiagen) and incubated for 5 min at 70 °C. 
Immediately after adding a solution containing 200 units of M-MLV reverse transcriptase 1x 
buffer (Promega) and 0.5 mM of each dNTP (Solis Biodyne), reverse transcription was 
continued by incubation for one hour at 37 °C. After retrieval of the cDNA, control and samples 
were mixed with the TaqMan Gene Expression assay probes (Thermo Fischer Scientific) and 
Faststart TaqMan Probe Master Mix (Roche Diagnostics) according to the manufacturer’s 
instructions. cDNA was amplified in a Corbett Rotor-Gene 6000 (Qiagen). An initial 
denaturation of 10 min at 95 °C was followed by 40 cycles of 15 sec at 95 °C and one min. at 
60 °C. Fluorescence was detected at 510 nm and data were collected using the “Rotor Gene Q 
– Pure Detection” Software (v. 2.3.1). All values were normalized to the expression of the 
housekeeping gene Glycerinaldehyd-3-phosphat-Dehydrogenase (GAPDH). 
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 2.5 Measurement of IL-8, RANTES, MCP-1 Secretion 
The experimental setup including the TNF-α concentration was chosen according to Park et al. 
[20], with some modifications. For the samples and controls, cells were seeded into 12-well 
plates at a density of 1.5x105 cells/mL. After an incubation time of 24 hours (37 °C, 5% CO2), 
DMEM with 10% (v/v) serum was discarded, cells were washed with one mL/well PBS and 
medium was exchanged to DMEM containing 0% FCS or the test solutions plus 20 ng/mL 
TNF-α. The second 24-hour period happened under the same conditions. Protein levels obtained 
from the untreated control are regarded as the basal secretion of the designated target in 
keratinocytes. In the end, supernatants were aspirated, stored in sterile micro centrifuge tubes 
and deep-frozen (-20 °C) immediately. Absorbance was measured at 450 nm using a microplate 
reader (Spectramax i3x Multimode detection platform, Molecular Devices).  
 
2.6 Statistical Analysis 
Data are shown as mean ± standard deviation (SD). ELISA experiments were performed in 
triplicates; each experiment was repeated at least three times (on different days). The protein 
levels were then calculated according to a standard curve. PCR experiments were executed in 
duplicates, a sample and one technical replicate; experiments were repeated at least five times 
(on different days). Results were processed according to the comparative CT Method (ΔΔCT-
Method; 
http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/
cms_042380.pdf) by the following equations using Microsoft Excel 2013 : 
(1) ∆𝐶𝑇 =  𝐶𝑇 𝑇𝑎𝑟𝑔𝑒𝑡 −  𝐶𝑇 𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 
 
(2) ∆∆𝐶𝑇 =  ∆𝐶𝑇 𝑡𝑒𝑠𝑡 𝑠𝑎𝑚𝑝𝑙𝑒 −  ∆𝐶𝑇 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑜𝑟 𝑠𝑎𝑚𝑝𝑙𝑒 
 
(3) 𝑆𝐷 (∆𝐶𝑇) = 𝑆𝐷 (∆∆𝐶𝑇) 
 
(4) 𝑓𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 = 2−∆∆𝐶𝑇 
 
(5) 𝑓𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 𝑟𝑎𝑛𝑔𝑒 =  2−(∆∆𝐶𝑇 ±𝑠) 
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To process the results by the comparative CT Method, the replication efficiency of the 
housekeeping gene and the targets have to be equal. The manufacturer of the TaqMan gene 
expression assays (Applied Biosciences) guarantees an amplification efficiency close to 100% 
(http://www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocume
nts/cms_040377.pdf). The term “down-regulation” refers to a gene expression level below the 
untreated control (<1), whereas “up-regulation” describes a level >1. Further statistical analysis 
was carried out by one-way analysis of variance (ANOVA) followed by Dunnett's multiple 
comparison test using the software package GraphPad Prism (version 6.01, GraphPad Software 
Inc.). In all cases, differences were considered significant if p was below 0.05. 
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3.  Results 
3.1 Gene Expression Inhibitory Activities of RF20-(SP-207), F(IV) and Ellagic Acid 
As a first step, the target-specific CT-values of cells treated by RF20-(SP-207), F(IV) (both 50 
µg/mL) and ellagic acid at 10 µM were detected, calculated to fold changes and compared to 
the control group (Figure 1A, C, E). In a second step, the target-specific CT-values of a sample 
set of the same substances each stimulated with 20 ng/mL TNF-α was obtained (Figure 1B, D, 
F). This set-up was used to simulate an inflammation state scenario in vitro. 
Figure 1A reveals a significant (p<0.001), 4.8-fold IL-1β-gene expression of the TNF-α 
stimulated control compared to the control group. However, there was no significant difference 
between the control group and the groups treated with the test substances. Figure 1B shows that 
all substances significantly (p<0.001) reduced the IL-1β-gene expression level ranging between 
20-fold for RF20-(SP-207) and 10-fold for ellagic acid compared to 90-fold of the stimulated 
control when they were concomitantly applied with 20 ng/mL TNF-α.  
Figure 1C displays that addition of TNF-α significantly increased IL-8 gene expression while 
the expression of IL-8 for RF20-(SP-207), F(IV) and ellagic acid remained on control level. 
When all test substances where concomitantly applied with TNF-α, the gene expression of IL-
8 was significantly downregulated if compared to the TNF-α group alone. (Figure 1D). It was 
of further interest to determine if RF20-(SP-207) or F(IV) have an effect on the transcriptional 
activity of IL-6. No treatment revealed a significant divergence compared to the unstimulated 
control (Figure 1E). When cells were stimulated with TNF-α, a 5-fold increase in IL-6 gene 
expression was observed (Figure 1 F). Interestingly, this increase could not be blocked by 
RF20-(SP-207). It has to be mentioned that the relative stimulation of the IL-6 transcription by 
the stimulated control was not as strong as the fold changes of stimulated controls tested for the 
other targets. The fold-change of ellagic acid exceeded the control clearly (9-fold vs. 5-fold), 
whilst only F(IV) caused a significant (p<0.1) reducing effect in gene expression to untreated 
control-level (Figure 1F). 
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Considering RANTES, the TNF-α-boosted control caused a significant (p<0.001) stimulation 
in gene expression (14.5-fold, Figure 2 A), while this was not the case for the unstimulated 
agents. The 2-ΔΔCT-values of RF20-(SP-207) and F(IV) remained at 1.5-fold and 1.6-fold, 
respectively. Merely the value of the ellagic acid-treated sample was slightly higher with 2.6 in 
fold change, however, not significantly different to the unstimulated control. This ratio is 
comparable to the TNF-α-stimulated set-up (Figure 2 B). In contrast to a 50-fold up-regulation 
of the boosted control, the extract and its fraction decreased the RANTES-gene-expression to 
6.6- and 5.6-fold, respectively. This diminishing effect was weaker under influence of ellagic 
acid (18-fold expression). Nevertheless, all stimulated substances caused significant (p<0.001) 
reducing effects.  
Figure 1: Transcriptional activity of selected chemokines in HaCaT keratinocytes under influence of RF20-
(SP-207) (50 µg/mL), F(IV) (50 µg/mL) and ellagic acid (10 µM). A fold change of IL-1β expression; B fold 
change of IL-1β with substances supplemented with TNF-α (20 ng/mL); C fold change of IL-8 expression; D 
fold change of IL-8 expression with substances supplemented with TNF-α (20 ng/mL); E fold change of IL-6 
expression; F fold change of IL-6 expression with substances supplemented with TNF-α (20 ng/mL). Data 
expressed as Mean ± SD of 2−∆∆𝐶𝑇.  N ≥ 3 independent experiments. A, C, E *** p<0.001 vs. Control; B, D, 
F *p<0.1, ***p<0.001 vs. Control + TNF-α. 
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Containing a c-c motif, MCP-1 belongs to the same family like RANTES. In both experimental 
set-ups, an intensive, significant (p<0.001) up-regulation of the stimulated control could be 
detected (Figure 2 C and D; 100 and 417-fold, respectively). Ellagic acid and F(IV) were 
determined at a 0.7- and 0.8-fold change and therefore generated a weak down-regulation 
(Figure 2 C). With a fold-change of 1, RF20-(SP-207) did not alter transcriptional activity 
compared to the untreated control. In contrast, fold-changes in the inflamed set-up were 
detected elevated (Figure 2 D). Nonetheless, 2-ΔΔCT-values of the three substances were 
discovered to be significantly (p<0.001) reduced compared to the stimulated control with a 417-
fold expression increase. Among the three sample agents, the expression-rate of F(IV) were 
detected at 58-fold, ellagic acid at 97-fold and RF20-(SP-207) at 149-fold. 
 
 
 
 
 
 
 
 
 
Figure 2: Transcriptional activity of selected chemokines in HaCaT keratinocyte under influence of RF20-
(SP-207) (50 µg/mL), F(IV) (50 µg/mL) and ellagic acid (10 µM). A fold change of RANTES expression; B 
fold change of RANTES expression with substances supplemented with TNF-α (20 ng/mL); D fold change of 
MCP-1 expression; E fold change of MCP-1 expression with substances supplemented with TNF-α (20 
ng/mL). Data expressed as Mean ± SD of 2−∆∆𝐶𝑇.  N ≥ 3 independent experiments. A, B ***p<0.001 vs. 
Control; C, D ***p<0.001 vs. Control + TNF-α. 
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3.2 Protein Secretion of IL-8, RANTES and MCP-1 
To investigate potential correlations of gene expression with protein secretion, IL-8, RANTES 
and MCP-1 were selected as biomarkers for ELISA-based assays. Comparability was ensured 
by choosing the same setting (unstimulated/stimulated) like in previous experiments.  
With 543 pg/mL, the IL-8 production in HaCaT keratinocytes was significantly (p<0.001) 
increased in the TNF-α-stimulated control (Figure 3 A). The levels of unstimulated samples 
ranged between 2.6 pg/mL for F(IV) and 7.8 pg/mL for ellagic acid. Yielding 8.3 pg/mL, the 
unstimulated control was negligibly higher. Cells under influence of TNF-α plus the particular 
substance secreted higher amounts of IL-8 with exception of F(IV). The addition of 50 µg/mL 
RF20-(SP-207) resulted in a protein level of 48 pg/mL, which relates to less than 10% of the 
level secreted by the stimulated control. Ellagic acid +TNF-α caused a secretion level of 175 
pg/mL relating to 32 % protein concentration of the stimulated control. However, all tested 
agents were capable to decrease the protein secretion significantly (p<0.001).  
By executing the ELISA assay detecting the RANTES release, it could be demonstrated that all 
tested agents possessed significant (p<0.001) decreasing properties on protein secretion 
compared to the stimulated control except ellagic acid supplemented with 20 ng/mL TNF-α 
(Figure 3 B). While all levels were in line with the unstimulated control (approx. 4 pg/mL 
RANTES), ellagic acid +TNF-α generated a protein raise up to 25.9 pg/mL, which was slightly 
higher than the stimulated control (23.4 pg/mL).  
The characteristics of RF20-(SP-207), F(IV) and ellagic acid were finalized by conducting the 
ELISA assay indicating MCP-1 as a biomarker (Figure 3C). In the unstimulated set-up, the 
concentrations under influence of each treatment accordingly did not alter significantly from 
the unstimulated control (approx. 10 pg/mL MCP-1). However, the inflamed scenario displayed 
a different picture. While treatment with 50 µg/mL of F(IV) caused a reduction of the protein 
level to 24 pg/mL MCP-1, RF20-(SP-207) reduced to an average of only 211 pg/mL. This value 
correlates to 9.5 % of the stimulated control and therefore also results in a significant (p<0.001) 
decrease. Exceptionally the treatment of ellagic acid + TNF-α did not decrease the MCP-1 level. 
Interestingly, yielding 2490 pg/mL in average, it mildly outperformed the stimulated control. 
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Figure 3: Differential regulation of ELISA-based protein secretion in HaCaT keratinocytes under influence 
of RF20-(SP-207) (50 µg/mL), F(IV) (50 µg/mL) and ellagic acid (10 µM) with and without supplementation 
of TNF-α (20 ng/mL). A IL-8 secretion; B RANTES secretion; C MCP-1 secretion. Data expressed as Mean 
± SD. N ≥ 3 independent experiments. ***p<0.001 vs. Control + TNF-α. ###p<0.001 vs. Control. 
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4.  Discussion 
In a previous study [14], we discovered a pronounced inhibitory effect of RF20-(SP-207) and 
F(IV) on human keratinocytes regarding proliferation and migration. Cellular reproduction and 
locomotive actions are closely related to events of inflammation [18]. Thus, the focus of this 
study was to explore the effect of RF20-(SP-207) and F(IV) on transcriptional activity of five 
different pro-inflammatory key targets in comparison to ellagic acid. As a follow-up 
investigation, three of these targets were examined in respect of their protein secretion.  
With IL-1β, IL-6, and IL-8 playing pivotal roles in events of inflammation [21-23], their 
differential gene modulation under influence of polyphenols were of interest. In this regard, 
numerous publications highlight the suppressive effects of flavonoids. For instance, Cho et. al. 
[24] reported a down-regulation of transcriptional activity of IL-1ß and IL-6 by treating RAW 
264.7 cells with various concentrations of quercetin in a dose- and time-dependent fashion. Min 
et. al. [25] exposed HMC-1 cells to quercetin and observed down-regulation of the gene 
expression of IL-1ß, IL-6 and IL-8. Albeit research is currently ongoing, one mechanism of 
these effects is discussed to occur by quercetin blocking the transcription factor NF-ĸB [26-28] 
and other serine/threonine kinases like the p38 mitogen activated protein kinase [25, 29]. 
Quercetin, kaempferol, ellagic acid and their derivatives are major compounds in RF20-(SP-
207), as well as in its sub-fraction (for compound analysis, see [17]). Despite differences in the 
cell line and mode of stimulation, the findings of the present study are widely in accordance 
with the literature within the meaning of IL-1ß, IL-6 and IL-8 gene expression modulation. 
However, the detection of a down-regulation of IL-1β and IL-8 gene expression by ellagic acid 
+ TNF-α compared to an increased protein secretion for the same targets was not as uniform as 
results obtained for RF20-(SP-207) and F(IV) for these targets. Kemp et. al. [30] analyzed 
cytokine expression levels in epithelial cells of human cervical tissue and found homogenous 
results for IL-8, but heterogeneous values for IL-6, which indicates a natural variance of the 
target. Nevertheless, our results of both, the transcriptional activity and the protein secretion, 
correlate for RF20-(SP-207) and F(IV) on IL-8, RANTES and MCP-1.  
RANTES and MCP-1 are chemokines with a chemotactic mode of action for various cell types 
and therefore, they are related in their mechanism [31]. For example, as a c-c motif member, 
RANTES recruits leukocytes to the site of action under the conditions of chronic inflammation 
[32]. Less extensive literature exists about the gene modulation of these two biomarkers under 
influence of polyphenols. Fukushima et al. [33] conducted a DNA microarray on HMC-1 
human mast cells after exposition of ellagic acid/quercetin containing Drosera species and 
demonstrated a down-regulation of these two biomarkers, IL-8 and IL-6 among others. For 
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instance, testing extracts of D. spatulata (2.63 % ± 0.31 ellagic acid; 0.41 % ± 0.09 quercetin), 
D. tokaiensis (1.09 % ± 0.17 ellagic acid; 0.53 % ± 0.07 quercetin) and D. rotundifolia (0.17 % 
± 0.04 ellagic acid; 0.45 % ± 0.05 quercetin) on human mast cells stimulated by activated T-
cell membranes, a gene modulation of MCP-1 resulted in 16.2 ± 5.2, 1.1 ± 0.5 and 1.7 ± 0.4-
fold, respectively, while the stimulated control was detected at 3012.3 ± 1443.9-fold. RANTES 
gene expression revealed a 2.9 ± 1.0 (D. spatulata), 0.8 ± 0.2 (D. tokaiensis) and a 1.2 ± 0.4-
fold change (D. rotundifolia) with a stimulated control at 88.0 ± 9.9-fold change. Interestingly, 
D. spatulata containing the highest amount of ellagic acid and the lowest amount of quercetin 
induced the highest value of fold change. The same accounts for IL-6 and IL-8. With a 1.8- and 
208.4-fold change, respectively, D. spatulata revealed the highest value among the three 
species. Taking these facts into account, our data correlate with published data. Thus, an 
involvement of the individual flavonoids present in RF20-(SP-207) on differential gene 
modulation can be assumed. This interpretation also accounts for the following observations. 
Regarding the ELISA-based results, the commonality of all of them is the surprisingly elevated 
protein level under influence of 10 µM ellagic acid supplemented with 20 ng/mL TNF-α. Since 
the level of the IL-8 assessment resulted in not more than 32 % of the stimulated control, a 
direct interaction between the polyphenol and the stimulant as well as a cross reactivity is 
excluded. Polyphenols, particularly flavonoids are known to have synergistic properties [34-
38]. Ellagic acid as a pure compound in combination with TNF-α revealed weak anti-
inflammatory potential on our selection of targets, whereas concomitant application of TNF-α 
and RF20-(SP-207) and its sub-fraction F(IV) possessed clear anti-inflammatory properties. 
Thus, in light of the aforementioned literature and the present data, a synergism of polyphenolic 
compounds in the fraction RF20-(SP-207), as well as in the sub-fraction F(IV) is assumed. 
 
5.  Conclusion 
Research on anti-inflammatory properties of flavonoids and their mechanism has been 
extensively reviewed in the literature. One favored approach is the analysis of the polyphenols’ 
effect on transcription factors like NF-ĸB or serine/threonine proteases, thereof possible 
downstream effects are then inferred. By focusing on very specific downstream targets that play 
pivotal roles in the direct inflammatory response, we illustrated the anti-inflammatory potential 
of RF20-(SP-207) and suggest this polyphenol-enriched fraction as a promising candidate for 
the treatment of acute and chronic inflammation. By valorization of a by-product of the rose oil 
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production, these findings also might be relevant for the establishment of a waste water 
management. 
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Appendix A. Supplementary data 
To provide detailed CT-values of the targets IL-1β, IL-6, IL-8, RANTES and MCP-1, ten tables 
are attached to this work displaying the means ± standard deviations for each biomarker. 
Supplementary data associated with this article can be found in the online version, at 
http://dx.doi.org/10.1016/j.fitote.2016.08.019.  
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Sample IL-1ß  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-1ß-
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 30.95 ± 0.50 19.70 ± 0.77 11.25 ± 0.92 0 ± 0.92 1 
(0.53 – 1.90) 
TNF-α  
[20 ng/mL] 
27.62 ± 0.75 18.61 ± 0.44 9.01 ± 0.87 -2.25 ± 0.87 4.8 
(2.60 – 8.68) 
RF20-(SP-207) 
[50 µg/mL] 
31.92 ± 1.05 19.37 ± 0.45 12.55 ± 1.16 1.30 ± 1.16 0.4 
(0.18 – 0.91) 
F(IV)  
[50 µg/mL] 
30.97 ± 1.42 19.00 ± 0.66 11.97 ± 1.56 0.72 ± 1.56 0.6 
(0.21 – 1.80) 
Ellagic acid  
[10 µM] 
31.75 ± 1.23 18.86 ± 0.81 12.88 ± 1.47 1.06 ± 1.47 0.3 
(0.14 – 1.67) 
 
Tab. 1: Values for target IL-1β (non-stimulated). Results express the Mean ± SD, N ≥ 3 independent 
experiments in duplicates. 
 
 
 
Tab. 2: Values for target IL-1β + TNF-α 20 ng/mL (stimulated). Results express the Mean ± SD, N ≥ 3 
independent experiments in duplicates. 
 
 
 
 
 
Sample IL-1ß  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-1ß-
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 37.02 ± 1.58 22.95 ± 0.22 14.07 ± 1.59 0 ± 1.59 1 
(0.33 – 3.02) 
TNF-α  
[20 ng/mL] 
29.75 ± 1.12 22.15 ± 1.24 7.60 ± 1.67 -6.47 ± 1.67 88.4 
(27.71 – 282.16) 
RF20-(SP-207) 
[50 µg/mL] 
32.30 ± 1.74 22.60 ± 0.43 9.71 ± 1.79 -4.36 ± 1.79 20.6 
(5.94 – 71.14) 
F(IV)  
[50 µg/mL] 
31.92 ± 1.85 21.63 ± 1.50 10.29 ± 2.38 -3.78 ± 2.38 13.8 
(2.64 – 71.75) 
Ellagic acid  
[10 µM] 
33.74 ± 3.34 23.04 ± 0.26 10.69 ± 3.35 -3.38 ± 3.35 10.4 
(1.02 – 105.99) 
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Sample IL-8  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-8-
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 32.74 ± 0.65 
 
19.70 ± 0.77 13.04 ± 1.01 0 ± 1.01 1 
(0.50 – 2.01) 
TNF-α  
[20 ng/mL] 
26.35 ± 0.57 18.61 ± 0.44 7.74 ± 0.72 -5.31 ± 0.72 39.5 
(24.04 – 65.01) 
RF20-(SP-207) 
[50 µg/mL] 
34.73 ± 2.52 19.37 ± 0.50 15.36 ± 2.57 2.32 ± 2.57 0.2 
(0.03 – 1.19) 
F(IV)  
[50 µg/mL] 
33.15 ± 2.02 
 
19.00 ± 0.66 14.16 ± 2.12 1.11 ± 2.12 0.5 
(0.11 – 2.01) 
Ellagic acid  
[10 µM] 
33.88 ± 0.17  18.86 ± 0.81 15.02 ± 0.82 1.98 ± 0.82 0.3 
(0.14 – 0.45) 
 
Tab. 3: Values for target IL-8 (non-stimulated). Results express the Mean ± SD, N ≥ 3 independent experiments 
in duplicates. 
 
 
 
Sample IL-8  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-8-
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 39.05 ± 1.26 
 
22.95 ± 0.22 16.10 ± 1.27 0 ± 1.27 1 
(0.41 – 2.42) 
TNF-α  
[20 ng/mL] 
30.03 ± 2.42 22.15 ± 1.24 7.89 ± 2.72 -8.21 ± 2.72 296.1 
(44.95 – 1950.52) 
RF20-(SP-207) 
[50 µg/mL] 
32.28 ± 2.58 22.60 ± 0.43 9.68 ± 2.62 -6.41 ± 2.62 85.3 
(13.89 – 523.95) 
F(IV)  
[50 µg/mL] 
31.55 ± 1.84 21.63 ± 1.50 9.92 ± 2.37 -6.18 ± 2.37 72.3 
(14.00 – 373.73) 
Ellagic acid  
[10 µM] 
36.30 ± 2.24 23.04 ± 0.26 13.25 ± 2.25 -2.84 ± 2.25 7.2 
(1.51 – 34.09) 
 
Tab. 4: Values for target IL-8 + TNF-α 20 ng/mL (stimulated). Results express the Mean ± SD, N ≥ 3 
independent experiments in duplicates. 
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Sample IL-6  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-6 - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 37.60 ± 1.32 
 
19.70 ± 0.77 17.89 ± 1.53 0 ± 1.53 1 
(0.35 – 2.89) 
TNF-α  
[20 ng/mL] 
32.29 ± 1.51 18.61 ± 0.44 13.67 ± 1.57 -4.22 ± 1.57 18.7 
(6.29 – 55.36) 
RF20-(SP-207) 
[50 µg/mL] 
36.98 ± 1.67 19.37 ± 0.50 17.62 ± 1.74 -0.28 ± 1.74 1.2 
(0.36 – 4.04) 
F(IV)  
[50 µg/mL] 
36.08 ± 2.56 19.00 ± 0.66 17.08 ± 2.65 -0.81 ± 2.65 1.8 
(0.28 – 11.00) 
Ellagic acid  
[10 µM] 
37.60 ± 1.39 18.86 ± 0.81 18.74 ± 1.61 0.84 ± 1.61 0.6 
(0.18 – 1.70) 
 
Tab. 5: Values for target IL-6 (non-stimulated). Results express the Mean ± SD, N ≥ 3 independent experiments 
in duplicates. 
 
 
 
Sample IL-6  
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
IL-6 - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 39.16 ± 1.29 
 
22.95 ± 0.22 16.20 ± 1.30 0 ± 1.30 1 
(0.41 – 2.47) 
TNF-α  
[20 ng/mL] 
35.97 ± 2.42 22.15 ± 1.24 13.83 ± 2.72 -2.38 ± 2.72 5.2 
(0.79 – 34.21) 
RF20-(SP-207) 
[50 µg/mL] 
36.80 ± 2.58 22.60 ± 0.43 14.20 ± 2.62 -2.00 ± 2.62 4.0 
(0.65 – 24.54) 
F(IV)  
[50 µg/mL] 
37.65 ± 2.30 21.63 ± 1.50 16.02 ± 2.75 -0.18 ± 2.75 1.1 
(0.17 – 7.60) 
Ellagic acid  
[10 µM] 
36.06 ± 3.54 23.04 ± 0.26 13.01 ± 3.55 -3.19 ± 3.55 9.1 
(0.78 – 106.64) 
 
Tab. 6: Values for target IL-6 + TNF-α 20 ng/mL (stimulated). Results express the Mean ± SD, N ≥ 3 
independent experiments in duplicates. 
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Sample RANTES 
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
RANTES - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 32.52 ± 1.84 
 
19.70 ± 0.77 12.82 ± 2.00 0 ± 2.00 1 
(0.25 – 4.00) 
TNF-α  
[20 ng/mL] 
27.57 ± 2.01 18.61 ± 0.44 8.96 ± 2.06 -3.86 ± 2.06 14.5 
(3.48 – 60.52) 
RF20-(SP-207) 
[50 µg/mL] 
31.51 ± 1.06 19.37 ± 0.50 12.14 ± 1.17 -0.68 ± 1.17 1.6 
(0.71 – 3.60) 
F(IV)  
[50 µg/mL] 
31.28 ± 0.60 19.00 ± 0.66 12.28 ± 0.88 -0.54 ± 0.88 1.5 
(0.79 – 2.68) 
Ellagic acid  
[10 µM] 
30.28 ± 0.46 18.86 ± 0.81 11.42 ± 0.93 -1.40 ± 0.93 2.6 
(1.39 – 5.02) 
 
Tab. 7: Values for target RANTES (non-stimulated). Results express the Mean ± SD, N ≥ 3 independent 
experiments in duplicates. 
 
 
 
Sample RANTES 
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
RANTES - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 39.05 ± 2.33 
 
22.95 ± 0.22 16.10 ± 2.34 0 ± 2.34 1 
(0.20 – 5.06) 
TNF-α  
[20 ng/mL] 
32.61 ± 2.76 22.15 ± 1.24 10.46 ± 3.03 -5.64 ± 3.03 49.7 
(6.09 – 405.63) 
RF20-(SP-207) 
[50 µg/mL] 
35.97 ± 5.50 22.60 ± 0.43 13.38 ± 5.51 -2.72 ± 5.51 6.6 
(0.14 – 300.26) 
F(IV)  
[50 µg/mL] 
35.25 ± 4.85 21.63 ± 1.50 13.62 ± 5.07 -2.47 ± 5.07 5.6 
(0.17 – 187.00) 
Ellagic acid  
[10 µM] 
34.96 ± 6.05 23.04 ± 0.26 11.92 ± 6.05 -4.18 ± 6.05 18.1 
(0.27 – 1200.72) 
 
Tab. 8: Values for target RANTES + TNF-α 20 ng/mL (stimulated). Results express the Mean ± SD, N ≥ 3 
independent experiments in duplicates. 
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Sample MCP-1 
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
MCP-1 - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 31.16 ± 1.06 
 
19.70 ± 0.77 11.46 ± 1.31 0 ± 1.31 1 
(0.40 – 2.48) 
TNF-α  
[20 ng/mL] 
23.40 ± 0.98 18.61 ± 0.44 4.78 ± 1.07 -6.67 ± 1.07 102.0 
(48.52 – 214.29) 
RF20-(SP-207) 
[50 µg/mL] 
30.70 ± 0.57 19.37 ± 0.50 11.33 ± 0.76 -0.13 ± 0.76 1.1 
(0.65 – 1.85) 
F(IV)  
[50 µg/mL] 
30.95 ± 1.03 19.00 ± 0.66 11.95 ± 1.22 0.50 ± 1.22 0.7 
(0.30 – 1.65) 
Ellagic acid  
[10 µM] 
30.63 ± 0.72 18.86 ± 0.81 11.77 ± 1.08 0.31 ± 1.08 0.8 
(0.38 – 1.70) 
 
Tab. 9: Values for target MCP-1 (non-stimulated). Results express the Mean ± SD, N ≥ 3 independent 
experiments in duplicates. 
 
 
 
Sample MCP-1 
 
Average CT 
 
GAPDH  
 
Average CT 
 
ΔCT  
 
MCP-1 - 
GAPDH 
 
ΔΔCT 
 
fold change  
 
= 2-ΔΔCT 
Untreated 36.75 ± 2.12 
 
22.96 ± 0.22 13.80 ± 2.13 0 ± 2.13 1 
(0.23 – 4.39) 
TNF-α  
[20 ng/mL] 
27.24 ± 2.46 22.15 ± 1.24 5.09 ± 2.76 -8.71 ± 2.76 417.6 
(61.77 – 2823.54) 
RF20-(SP-207) 
[50 µg/mL] 
29.18 ± 2.81 22.60 ± 0.43 6.58 ± 2.85 -7.22 ± 2.85 148.8 
(20.69 – 1069.45) 
F(IV)  
[50 µg/mL] 
29.57 ± 2.33 21.63 ± 1.50 7.94 ± 2.77 -5.86 ± 2.77 57.9 
(8.49 – 394.46) 
Ellagic acid  
[10 µM] 
30.24 ± 3.84 23.04 ± 0.26 7.19 ± 3.85 -6.60 ± 3.85 97.3 
(6.77 – 1398.91) 
 
Tab. 10: Values for target MCP-1 + TNF-α 20 ng/mL (stimulated). Results express the Mean ± SD, N ≥ 3 
independent experiments in duplicates.  
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4. Conclusion and Outlook 
This work selected parts of Phyllostachys edulis (Carrière) J. Houz. (Poaceae) and Rosa 
damascena Mill. (Rosaceae) for further analyzation because of their high contents of 
polyphenols, which are known for their diverse biological effects (chapter 2.3). Moreover, 
both plants are utilized in the industrial fabrication of typical products of their country of 
origin the Republic of Bulgaria and the People’s Republic of China, respectively. Essentially, 
inflammation key targets as well as wound closure characteristics were of interest from a 
pharmaceutical point of view. Due to the accumulation of tons of waste fractions within the 
production line, valorization options of the by-products of Phyllostachys edulis and Rosa 
damascena was also one aspect from an ecological point of view. Because of this, herein it 
was investigated in anti-inflammatory, proliferative, and cell locomotive properties of phenol-
rich resources of the two species.  
In planta, polyphenols can have defensive functions, for example to deter herbivores, or act as 
an attractant like flavonoids attract organisms intending pollination or seed dispersal for 
survival and propagation (see chapter 2.3). The literature has extensively described pleiotropic 
actions in terms of pharmacological effects, especially outcomes based on in vitro-conditions. 
Among them, anti-oxidant and radical scavenging characteristics are two of the most 
prominent ones. Nevertheless, results of both in vitro- and in vivo-studies are discussed 
controversially because of certain difficulties in the realization of these experiments as 
described in chapter 2.3. 
Anti-inflammatory and migrative/proliferative effects of Phyllostachys edulis  
Phyllostachys edulis, also known as moso bamboo, is cultivated widely on the Asian 
continent and its wood is utilized for lots of different purposes in Chinese culture (see chapter 
2.2). During the harvest, tons of polyphenol-containing leaves accumulate, which have no 
noteworthy further use for pharmaceutical purposes up-to-date. Therefore, the leaves were 
subjected to aqueous Soxhlet extraction and subsequent lyophilization to obtain the bamboo 
leave extract (BLE) for further processing. HPLC analysis with subsequent LC-MS/MS 
identified isoorientin as one of the main flavonoids with amounts of 5,32 g/kg and thus, was 
selected for subsequent experimentation. Pretreatment of HaCaT keratinocytes with 
isoorientin at 50 μM and 100 μM caused a significant reduction of cellular IL-6 secretion 
comparable to the positive control hydrocortisone (10 μM), while cell viability was not 
impaired throughout the incubation time. On the contrary, BLE could not exert a significant 
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reduction of cellular IL-6 secretion, which emphasizes on the specific capability of isoorientin 
to reduce IL-6 levels. Presumably, the concentration of isoorientin in BLE was too low to 
cause such effect. Furthermore, isoorientin also significantly decreased TNF-α-induced 
VEGF- and IL-8 secretion in a dose dependent fashion. These results stand in good 
accordance with reports in the literature (see 3.1 Discussion). Moreover, wound closure 
effects of 3T3-swiss albino mouse fibroblasts have been assessed utilizing a computerized 
method of the classical scratch assay with support of time lapse microscopy. In this context, 
fibroblasts as well as keratinocytes as epidermal cell lines play a crucial role in the healing of 
tissue damages (see chapter 2.5). 12- and 24-hour observations caused comparable outcomes 
of approximately 28% and 55% gap closure by the extract and isoorientin at 10 μg/mL and 10 
μM, respectively. In higher concentrations of both agents individually, cell migration was 
inhibited without considerable toxic effects on cell viability. A hypothesis for this 
circumstance is partly the reduction of cellular VEGF secretion, which is necessary for a 
proper creation of ECM and cutaneous angiogenesis. 
Anti-inflammatory and migrative/proliferative effects of Rosa damascena 
Bulgaria is the world’s biggest rose oil producer, which is essentially used as a food 
ingredient or in cosmetic formulations. Farmers cultivate Rosa damascena on vast fields in 
the heartland of Bulgaria. Employing a certain method of water steam distillation in which for 
each kilogram of flowers the four-fold quantity of water is necessary, phenol-rich liquid waste 
residues (RODW) accumulate resulting in about 30.000 tons annually with no further use up-
to-date (see chapter 2.2). Purification of RODW resulted in a polyphenol depleted and a 
polyphenol enriched fraction [(RF20-(SP-207)], of which the latter one was split into four 
sub-fractions F(I)-F(IV) depending on the phytochemical spectrum of polyphenolic 
compounds. Both for RF20-(SP-207) and F(IV), anti-proliferative effects were detected, 
which was concluded by significantly decreased BrdU-values in de novo synthesized DNA, as 
well as reduced cellular VEGF-expression levels. Since cellular reproduction and locomotive 
actions are interrelated with inflammatory processes, wound closure properties were of 
substantial interest. 24h-time lapse microscopy detected a retarded wound closure of human 
keratinocytes under influence of RF20-(SP-207) at 10 μg/mL, while F(IV) at 10 μg/mL 
almost caused an abrogation. By comparison with morphologic changes of the cell structure 
under influence of anisomycin at 10 μM, an elevated rate of apoptosis is assumed by both 
compounds individually at the same concentrations as used before. A follow up-study (see 
chapter 3.3) investigated in the transcriptional activity of the pro-inflammatory key targets IL-
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1β, IL-8, IL-6, RANTES and MCP-1 under influence of RF20-(SP-207) and F(IV) by 
utilizing real time quantitative RT-PCR. Concomitant application of TNF-α and RF20-(SP-
207) or TNF-α and F(IV), respectively, uncovered comparable results suggesting an 
inflammatory downregulation. Further analyzation in terms of cellular protein secretion of IL-
8, RANTES and MCP-1 has been done subsequently. Therein, significantly reduced secretion 
levels were detected. 
Limitations in the comparison of Phyllostachys edulis and Rosa damascena as polyphenol 
containing species 
The previously described results create a picture of polyphenol containing plants with distinct 
profiles of pharmacological in vitro-effects. In this context, it must be mentioned that the 
experimental focus of the work predominantly was put on the rose flower, for which reason 
investigation in this species has been more profound.  
As a similarity, it can be said that the utilized substances of both plants exert anti-
inflammatory effects based on the regulation of cellular secretion of pro-inflammatory 
cytokines. The exact mechanisms exerted by the two species remain to be elucidated, 
however, it can be assumed to have different pathways involved: first because of the 
individual composition of compounds and second because of the sheer intensity of the 
detected anti-inflammatory properties. For instance, with isoorientin decreasing significantly 
cellular IL-6 levels, but not BLE, and effects caused by substances from the rose flower being 
substantially different than those of the bamboo leaves, it can be noticed that the structure-
activity relationship is a complex matter for such multicomponent systems.  
Clear differences accounting for locomotive actions were observed in time lapse experiments. 
In brief, while bamboo enhanced cell migration, the rose flower impaired it. However, it must 
be kept in mind that these findings were generated by using two different cell lines: 3T3-swiss 
albino mouse fibroblasts in the first case and HaCaT keratinocytes in the second (because of 
substance- and hardware-specific compatibility). Different cell lines have individual 
migration speeds, reproduction cycles, sensitivities regarding compound tolerance etc. 
Although both are epidermal cell lines, the comparability thus is limited. Above all, in vitro 
cell cultures are imperfect systems when simulating in vivo conditions, especially mono-
cultures. There exist multi-cultures, but their partly intricated cultivation methods are not 
payed back by the findings in most cases, for which reason animal models might be preferred 
as a next step. Additionally, because of previously obtained results and time and budget 
reasons, RT-PCR experiments have been exclusively conducted using the fraction from 
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RODW. Thus, a more detailed picture can be drawn of the pharmacological effects exerted by 
Rosa damascena. Albeit biological effects of prominent single polyphenols like quercetin, 
kaempferol, catechins and lots more are well described in the literature, the complexity of 
such multicomponent mixtures hinder a reliable prediction regarding their pharmacology. Not 
only there are interspecific differences between the species, but also intraspecific variations 
due to the intensity of the sun, soil quality, rainfall etc. Hence, detailed research of every 
candidate is indispensable for the analysis of pharmacological effects. 
Future perspectives  
Different to by-products of the damask rose, there already exist few health/beauty related 
lifestyle products made of bamboo plants on the market (for example 
www.organicbamboo.org). To our knowledge, this is the first study analyzing the effects of 
moso bamboo on specific pro-inflammatory targets of epidermal cells. Deeper investigation 
on specific mechanisms of a broader range of targets with involvement of subsequent in vivo-
studies would be necessary to extend the knowledge about the pharmacological profile. The 
previously described results might trigger an impulse for further elucidation. Based on these 
findings and on the limited bioavailability of polyphenols including strong first-pass effects, 
the substance could pose an interesting treatment option to promote wound healing and 
decrease inflammations in a topical application form such as semisolids (gels, cremes, 
ointments etc.) or bio-degradable solid forms (transdermal patch) to enable a local therapy. 
Moreover, chemical synthesis of flavonoids is cost-intensive and complex to achieve and 
therefore not a feasible option, at least not in a large-scale production. Therefore, a natural 
source of raw material is of high importance. 
The pharmacological in vitro-effects of the damask rose, like compromising sequences in the 
cell cycle among others, offer several interesting treatment options of principally 
hyperproliferation- and/or chronic inflammation-involved skin diseases such as psoriasis for 
instance. Therefore, again in vivo-studies are indispensable, however, a topical application 
form because of bioavailability-/toxicity-/solubility-related issues for a local therapy is 
conceivable. Additionally, in vivo-related parameters like stability, penetration characteristics 
and of course skin tolerance etc. must be assessed.  
Considering the rising pressure on natural resources at present time, sustainability gains 
importance. In this context, the question of cost-effective up-scaling options to industrial 
standards of the polyphenol extraction of the damask rose is crucial (Fig. 4, chapter 2.2).  
Conclusion and Outlook   
132 
 
Rusanov et al. [1] used activated absorption resins to efficiently obtain polyphenol-enriched 
RODW and therein suggest a medium-scale system. This could serve as a foundation for 
further optimization regarding the efficiency of extraction and cost reduction. In any case, it is 
of utmost relevance for the world’s population to remember the respect for clean air, water 
and food, which are the basic biological needs for every creature. To secure them, it is 
necessary to optimize the utility of resources, which starts in the very beginning of the food 
chain and other production lines. Within this work, pharmacological in vitro-effects of two 
natural resources were successfully characterized, which could pose an interesting option for a 
beneficial treatment method. As a follow-up study, it would be fascinating to assess in vivo 
effects in animal and human skin models, as well as to assess to which extent the existing in 
vitro results stand in accordance with them. Moreover, technological examinations are 
necessary to incorporate the compounds -or a certain fraction- into an appropriate form of 
application. Subsequently, just like a further benefit of bamboo leaves, waste water of the rose 
oil production could be collected for further processing and thereby converted into an 
uncritical state for disposal. Altogether, the previously reported results offer the basis for 
potentially new strategies to valorize an original waste fraction to a value-added product. 
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